Introduction {#s1}
============

*Saccharomyces cerevisiae* is an invaluable model for cell biology ([@bib56]). Despite the simplicity of its genome, its inner working mechanisms are similar to that of higher eukaryotes. Furthermore, its ease of handling allows large-scale screenings. Yeast genetic screens have classically been performed by random mutagenesis, followed by a selection process that identifies interesting mutants. However elegant the 'tricks' implemented to expose the sought-after mutants, this selection phase remains a tedious process of finding a needle-in-a-haystack ([@bib56]). The selection phase can limit the throughput and the saturation of classical yeast genetic screens.

To circumvent these problems, a second-generation genetic screening procedure has been developed. Ordered deletion libraries for every non-essential gene have been generated ([@bib18]). The growth of each individual deletion strain can be assessed, either by robot-mediated arraying, or by competitive growth of pooled deletion strains, followed by detection of 'barcodes' that identify each deletion strain. These second-generation approaches also have limitations. First, ordered libraries of complete deletions only cover non-essential genes. Second, deletion strains are prone to accumulate suppressor mutations ([@bib49]). To alleviate these problems, deletion libraries can be propagated in a diploid-heterozygous form. Additional steps are then required to make them haploid. In addition, while single genetic traits can be crossed into a pre-existing library, allowing for instance pairwise genetic-interaction analysis ([@bib12]), introducing multiple and/or sophisticated genetic perturbations becomes problematic, since crossing requires a selection marker for each important trait. Typically, deletion libraries are missing in most biotechnology-relevant backgrounds. Finally, manipulating ordered libraries requires non-standard equipment, such as arraying robots, limiting the pervasiveness of these approaches.

Recently, an innovative approach called Transposon sequencing (Tn-seq) was developed in various bacterial models ([@bib11]; [@bib19]; [@bib52]), and in the fungus *Schizosaccharomyces pombe* ([@bib20]). By allowing *en masse* analysis of a pool of transposon mutants using next-generation sequencing, this strategy eliminates the drawbacks of previous genetic screens.

Here, we describe an adaptation of the Tn-seq strategy for *S. cerevisiae*, that combines the advantages of both first and second generation screens, while alleviating their limitations. The method is based on the generation of libraries of millions of different clones by random transposon insertion ([Figure 1A](#fig1){ref-type="fig"}). Transposons inserted in genes that are important for growth kill their hosts and are not subsequently detected. These genes therefore constitute transposon-free areas on the genomic map. Transposon-based libraries can be grown in any condition to reveal condition-specific genetic requirements. Unlike ordered deletion libraries, transposon-based libraries can easily be generated de novo from different strain backgrounds, are not limited to coding sequences and do not require the usage of robots.10.7554/eLife.23570.003Figure 1.Principle of the method.(**A**) Outline of the experimental procedure. Left, the transposon (green) can insert either into non-essential DNA (blue) and give rise to a clone, or into essential DNA (orange), in which case no clone is formed. Right, procedure to identify transposon insertion sites by deep-sequencing. (**B**) Profile of the transposon density across the whole genome, when the transposon original location is either a centromeric plasmid (top) or the endogenous *ADE2* locus on chromosome XV (bottom). The dashed lines indicate the chromosome centromeres. (**C**) Six examples of genomic regions and their corresponding transposon coverage in seven independent transposon libraries of indicated genotypes. Each vertical grey line represents one transposon insertion event. Genes annotated as essential are shown in orange, others in blue. Green arrowheads indicate the places where the absence of transposon coverage coincides with an essential gene. (**D**) Histogram of the number of transposons found in every annotated gene (CDS). The vertical dashed line is the median of the distribution. (**E**) Same as D, with genes categorized as non-essential (blue) and essential (orange) according to previous annotations.**DOI:** [http://dx.doi.org/10.7554/eLife.23570.003](10.7554/eLife.23570.003)10.7554/eLife.23570.004Figure 1---figure supplement 1.Size distribution of the colonies appearing on SD +Galactose -Ade.(**A**) Histogram of colony area for a randomly chosen sample of 402 colonies. (**B**) Example of picture of colonies (top) and segmentation thereof (bottom) used to calculate histogram in (**A**). Scale bar, 1 mm.**DOI:** [http://dx.doi.org/10.7554/eLife.23570.004](10.7554/eLife.23570.004)10.7554/eLife.23570.005Figure 1---figure supplement 2.Genome-wide analysis of transposon insertion sites.(**A**) Frequency plot of nucleotide composition around transposon insertion site. The strand is determined according to the orientation of the transposon insertion. Plot was calculated with a random sample of 50,000 transposon in the wild-type library 1. Note that GC-content of the yeast genome is 38%. (**B**) Preferential transposon insertion into internucleosomal DNA. Three genomic regions are shown. For each, the top panel shows the nucleosomal density as determined in ([@bib34]), and the bottom panels show transposon insertion as in [Figures 2](#fig2){ref-type="fig"}--[5](#fig5){ref-type="fig"}. (**C**) Correlation analysis of nucleosome and transposon density. Transposon densities were calculated on the wild-type library 1 by averaging transposon number within a 40 bp moving average. Top, correlation coefficient calculated between the nucleosome and the transposon data offset by the indicated number of bp. The correlation is most negative when offset = 0. The periodicity is \~160 bp. Middle, autocorrelation of transposon data. The periodicity is identical as above. Bottom, autocorrelation of the nucleosome density data. The periodicity is identical as above. (**D**) Analysis of transposon number relative to distance from centromere. For each chromosome, the number of transposons mapping within a certain distance from their respective centromere was computed and plotted (grey lines). The number of transposons increases linearly with the distance, except in the vicinity of the centromere, where transposon enrichment can be observed. The intercept of the linear regression, computed on the linear part of the plot and multiplied by 16 chromosomes, gives a rough estimate of the numbers of transposons enriched at pericentromeric regions (\~20% of the total transposon number).**DOI:** [http://dx.doi.org/10.7554/eLife.23570.005](10.7554/eLife.23570.005)10.7554/eLife.23570.006Figure 1---figure supplement 3.Transposon density in essential and non-essential genes.As in [Figure 1D--E](#fig1){ref-type="fig"}, except that, for each gene, the transposon density (i.e. number of transposons divided by length of the gene) is shown.**DOI:** [http://dx.doi.org/10.7554/eLife.23570.006](10.7554/eLife.23570.006)

This method can successfully uncover sets of genes essential in given conditions, genome-wide genetic interactions and drug-targets. Transposon insertions can generate loss- and gain-of-function variants. Finally, our approach not only shows which protein is important for growth, but also which part of the protein is essential for function, allowing genome-wide mapping of structural protein domains and screening of phenotypes at a sub-gene resolution.

Results {#s2}
=======

Library generation {#s2-1}
------------------

The detailed procedure can be found in the Materials and methods section. The method utilizes the Maize Ac/Ds transposase/transposon system in yeast ([@bib33]; [@bib55]). Briefly, cells in which the *ADE2* gene is interrupted by the MiniDs transposon are induced to express the transposase Ac, on galactose-containing adenine-lacking synthetic defined medium (SD +galactose -adenine). Transposase-induced MiniDs excision is followed by repair of the *ADE2* gene. Cells with repaired *ADE2* will be able to form colonies. The excised transposon then re-inserts at random genomic locations with a frequency of \~60% ([@bib33]).

We have generated seven libraries, displayed together in all figures to illustrate the reproducibility of the approach. All libraries were generated in *ade2Δ* strains derived from BY4741 and BY4742 backgrounds. Additional mutations (*dpl1Δ*, *dpl1Δ psd2Δ*, *VPS13(D716H), mmm1Δ VPS13(D716H), YEN1^on^,* [Table 1](#tbl1){ref-type="table"}) will be described in the following sections. The complete dataset is available ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}) and searchable here: <http://genome-euro.ucsc.edu/cgi-bin/hgTracks?hgS_doOtherUser=submit&hgS_otherUserName=benjou&hgS_otherUserSessionName=23bDePuYrk>10.7554/eLife.23570.007Table 1.Characteristics of the libraries**DOI:** [http://dx.doi.org/10.7554/eLife.23570.007](10.7554/eLife.23570.007)***Library**Number of colonies**Reads mapped**Transposons mapped**Median read per transposon**Number of MiSeq runs**Overlap between MiSeq runs***Wild-type 1\~1.6×10^6^31794831284162222^\*^54%, 88%^\*^Wild-type 2\~2.4×10^6^15303285258568121NA*VPS13(D716H)*\~4.7×10^6^24958456414114132^†^41%, 42%^†^*Mmm1Δ*\
*VPS13(D716H)*\~1.9×10^6^17799948303323121NA*dpl1Δ*\~2.3×10^6^1507715640112681NA*dpl1Δ psd2Δ*\~2.9×10^6^1164956136317991NA*YEN1^on^*\~2.8×10^6^951787749512561NAWild-type 2 + rapamycin\~2.4×10^6^966495616932291NA[^1][^2]

Detection of transposon insertion sites {#s2-2}
---------------------------------------

Typically 7,000--10,000 colonies with a narrow size distribution ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) can be generated on a 8.4 cm-Ø petri dish. In the case of wild-type library 1, 240 plates yielded \~1.6E6 clones ([Table 1](#tbl1){ref-type="table"}). To detect transposon insertion sites, transposed cells were scraped off the 240 plates and pooled ([Figure 1A](#fig1){ref-type="fig"}). This pool was used to reinocculate SD medium lacking adenine (SD +Dextrose -Adenine), and the culture was grown to saturation. This step was used to dilute non-transposed *ade-* cells still present on the petri dishes. The culture was then harvested by centrifugation. Genomic DNA was extracted and digested with frequent-cutting restriction enzymes, followed by ligase-mediated intramolecular circularization. Circular DNA was PCR-amplified using transposon-specific outwards-facing primers. PCR products were then sequenced on a MiSeq machine ([Figure 1A](#fig1){ref-type="fig"}).

Analysis of transposon insertion sites {#s2-3}
--------------------------------------

We aligned the sequencing reads of the wild-type library ([Table 1](#tbl1){ref-type="table"}) to the reference yeast genome and counted the number of mapped transposons. To account for the fact that Illumina sequencing is imperfectly accurate, we considered that two reads of the same orientation mapping within two bp of each other originated from the same transposon (see [Source code 1](#SD4-data){ref-type="supplementary-material"}). In this analysis, 284,162 independent transposons could be mapped onto the genome, representing an average density of one transposon every 42 bp, and a median number of 22 reads per transposon. No large area of the genome was devoid of transposon ([Figure 1B](#fig1){ref-type="fig"}). Consistent with analyses in Maize ([@bib53]), no strong sequence preference was detected in the insertion sites ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}).

In many instances, though, insertion frequency was modulated along the genome with a periodicity of \~160 bp. Superimposing nucleosome occupancy data ([@bib34]) showed that this was due to favored transposon insertion in inter-nucleosomal DNA ([Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}, [@bib17]). This effect can be appreciated at the genome-scale. Indeed, an autocorrelation analysis unraveled a \~160 bp periodic signal in the genome-wide transposon density (measured using a 40 bp moving average, [Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"}). This periodicity was comparable to that of the nucleosomal density data ([@bib34]). Finally, while no large region was devoid of transposon, some regions were actually preferentially targeted by transposons. These were the pericentromeric regions ([Figure 1B](#fig1){ref-type="fig"}, top), which were specifically enriched by \~20% of the transposon insertions ([Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"}). The explanation for this phenomenon may pertain to nuclear architecture and to the propensity of our transposon to insert close to its excision site ([@bib33]). Because the transposon is initially excised from a centromeric plasmid, and because centromeres cluster in the nuclear periphery ([@bib27]), the transposon might tend to reinsert in the pericentromeric regions of other chromosomes. We confirmed this assumption by sequencing a small-scale library (\~30 000 insertions mapped) in which the MiniDS transposon was originally at the endogenous *ADE2* locus, rather than on a centromeric plasmid. In this library, preferential targeting was not observed at pericentromeric regions, but rather in the vicinity of *ADE2*, confirming our assumption ([Figure 1B](#fig1){ref-type="fig"}, bottom).

Identification of essential genes {#s2-4}
---------------------------------

The transposon map clearly showed that a fraction of the coding DNA sequences (CDS) were devoid of insertions. These coincided almost exactly with genes annotated as essential ([Figure 1C](#fig1){ref-type="fig"}, green arrowheads). The median number of transposons inserted in the CDSs of all genes was 18 per gene ([Figure 1D](#fig1){ref-type="fig"}). This number raised to 21 for annotated non-essential genes, but dropped to three for annotated essential genes ([Figure 1E](#fig1){ref-type="fig"}). This decrease was not due to a difference in the length between essential and non-essential genes, since normalizing the number of transposon insertions to the CDS length (transposon density) did not abrogate this effect ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). Thus our method distinguishes, in a single step, genes that are required for growth from those that are not.

Several genes, although annotated as non-essential, harbored no or very few transposons ([Supplementary file 2](#SD2-data){ref-type="supplementary-material"}). This can be attributed to the following reasons. (1) Because sequencing reads mapping to repeated sequences were discarded during alignment, repeated genes appear as transposon-free. (2) Several annotated dubious ORFs overlap with essential genes, and thus appear as transposon-free. (3) Several genes are necessary for growth in particular conditions, and are therefore not annotated as essential, yet are required in our growth conditions (SD +galactose -adenine). These include genes involved, for instance, in galactose metabolism and adenine biosynthesis.

Identification of protein domains {#s2-5}
---------------------------------

It came as a surprise that some genes annotated as essential were tolerant to transposon insertion. While some of these clearly corresponded to annotation inconsistencies, many reflected an unanticipated outcome of our approach. We observed many instances of 'essential' CDSs containing transposon-permissive regions. A striking example is *GAL10* ([Figure 2A](#fig2){ref-type="fig"}). *GAL10* encodes a bifunctional enzyme with an N-terminal epimerase, and a C-terminal mutarotase domain ([@bib36]). While the epimerase activity is indispensable in our conditions, the mutarotase activity is dispensable, as cells were fed a mixture of α- and β-D-Galactose, thus not requiring the conversion of one into the other. In accordance, the 3' end of *GAL10* was permissive for transposon insertion. The junction between the permissive and non-permissive domains of *GAL10* corresponds exactly to the junction of the two domains in the Gal10 protein. Several examples of essential genes with dispensable 3'-ends are shown in [Figure 2A](#fig2){ref-type="fig"}. We confirmed the dispensability of the 3\' end for two genes, *TAF3* and *PRP45* ([Figure 3](#fig3){ref-type="fig"}).10.7554/eLife.23570.008Figure 2.Examples of genes showing partial loss of transposon coverage.The grey level is proportional to the number of sequencing reads. Known functional domains are indicated. (**A**) Essential genes for which C-terminal truncations yield a viable phenotype. (**B**) Essential genes for which N-terminal truncations yield a viable phenotype. (**C**) Essential genes for which various truncations yield a viable phenotype.**DOI:** [http://dx.doi.org/10.7554/eLife.23570.008](10.7554/eLife.23570.008)10.7554/eLife.23570.009Figure 2---figure supplement 1.Detection of essential protein domains.Top, algorithm to detect essential protein domains. This algorithm is implemented in [Source code 2](#SD5-data){ref-type="supplementary-material"}. For each gene, a score is computed as follows: the longest interval between transposon n and transposon n + 5, multiplied by the total number of transposons mapping to that gene, divided by the gene length to the power of 1.5. A score of 0 is assigned to genes targeted by less than 20 transposons, in which the longest interval is smaller than 300 bp, and/or in which the longest interval represents more than 90% or less than 10% of the CDS length. Bottom, yeast genes sorted according to their domain likelihood score. Vertical black bars above the graph indicate previously annotated essential genes.**DOI:** [http://dx.doi.org/10.7554/eLife.23570.009](10.7554/eLife.23570.009)10.7554/eLife.23570.010Figure 2---figure supplement 2.Transposon maps in the 100 highest scoring genes.Grey scale indicates the number of sequencing reads as in [Figure 2](#fig2){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.23570.010](10.7554/eLife.23570.010)10.7554/eLife.23570.011Figure 2---figure supplement 3.Transposon maps in the genes scoring 101 to 200.**DOI:** [http://dx.doi.org/10.7554/eLife.23570.011](10.7554/eLife.23570.011)10.7554/eLife.23570.012Figure 2---figure supplement 4.Transposon maps in the genes scoring 201 to 300.**DOI:** [http://dx.doi.org/10.7554/eLife.23570.012](10.7554/eLife.23570.012)10.7554/eLife.23570.013Figure 2---figure supplement 5.Transposon maps in the genes scoring 301 to 400.**DOI:** [http://dx.doi.org/10.7554/eLife.23570.013](10.7554/eLife.23570.013)10.7554/eLife.23570.014Figure 3.*TAF3* and *PRP45* can be truncated without visible effects on cell growth.(**A**) A truncation of *TAF3* was generated in a heterozygous diploid strain (left) by introduction of an HA tag and a G418-resistance cassette (HA kan^r^). The strain was tetrad dissected (middle). Tetrads 2 and 3 were further analyzed by PCR to confirm the Mendelian segregation of the truncated allele (right). (**B**) A complete *TAF3* deletion was generated in a heterozygous diploid strain (left) by introduction of a G418-resistance cassette (kan^r^). Meiosis yields only two viable, G418-sensitive spores per tetrad, confirming that *TAF3* complete deletion is lethal. (**C--D**) As in (**A--B**) but applied to *PRP45*. Asterisks in the right panel designate PCR reactions that were inefficient at amplifying the large truncated allele. The genotype of these spores can nevertheless be inferred from the Mendelian segregation of the G418 resistance. (**E**) Top, cryo-EM structure of the *S. cerevisiae* spliceosome (PDB accession 5GMK, [@bib54]). Bottom, the same structure stripped of every protein except Prp45. The essential portion of Prp45 as defined in (**C**) is in green and the non-essential part is in red and yellow. U2, U6, U5 and substrate RNAs are depicted in pale blue, pink, dark blue and orange, respectively. The red circle indicates the catalytic active site of the spliceosome. (**F**) Alignment of the Human, *S. cerevisiae*, and *S. pombe* Prp45 orthologs. The green, red and yellow boxes are colored as in (**E**). The yellow box features the most conserved region of the protein.**DOI:** [http://dx.doi.org/10.7554/eLife.23570.014](10.7554/eLife.23570.014)

*TAF3* encodes a 47 kDa central component of TFIID ([@bib43]). Our data show that only the first 76 amino acids are necessary for growth. Using homologous recombination, we replaced all but the sequence coding for the first 90 amino acids with an HA tag and a G418-resistance cassette (*KanMX6*) in a diploid strain. Sporulation and progeny segregation confirmed that strains expressing only the first 90 amino acids of Taf3 were viable ([Figure 3A](#fig3){ref-type="fig"}). By contrast, complete replacement of *TAF3* gave rise to only two viable, G418-sensitive spores per meiosis, confirming that *TAF3* is essential ([Figure 3B](#fig3){ref-type="fig"}). The essential region of Taf3 corresponds to a predicted histone-like bromo-associated domain ([@bib13]).

*PRP45* encodes a central component of the spliceosome. From our data, only the first 140 amino-acids of Prp45 are necessary for growth, which we confirmed using the same strategy as for *TAF3* ([Figure 3C--D](#fig3){ref-type="fig"}). Prp45 is predicted to be intrinsically disordered, thus no clear domain boundaries are available to rationalize our data. However, a recent cryo-EM structure of the *S. cerevisiae* spliceosome offers clues on the structure of Prp45 ([@bib54]). Prp45 is centrally located within the spliceosome, has an extended conformation and makes several contacts with various proteins and snRNAs. In particular, the most conserved region of Prp45 is a loop that makes extensive contacts with U2 and U6 snRNAs close to the active site ([Figure 3E--F](#fig3){ref-type="fig"}, yellow). This loop belongs to the dispensable part of Prp45, surprisingly suggesting that splicing can occur without it. Our method thus offers insights that neither sequence conservation nor structural analysis could have predicted.

We also observed CDSs in which the 5' end is permissive for transposon insertion while the 3' end is not ([Figure 2B--C](#fig2){ref-type="fig"}). Again, our data show a general good coincidence between indispensable regions and annotated domains. It is surprising that transposons can be tolerated in the 5' of such genes, since several stop codons in all frames of the transposon should interrupt translation and prevent the production of the essential C-terminus. We speculate that the production of the C-terminus is enabled by spurious transcription events. A remarkable example is *SEC9* ([Figure 2C](#fig2){ref-type="fig"}). *SEC9* encodes a SNARE protein. The essential SNARE domain, located at the C-terminus ([@bib8]), is devoid of transposons. The N-terminus of the protein is known to be dispensable for growth ([@bib8]). We indeed observe several transposons inserted upstream of the SNARE domain. The extreme 5' of the gene constitutes another transposon-free region even though it encodes a dispensable part of the protein ([@bib8]). It is possible that transposon insertion in this 5' region generates an unexpressed, unstable or toxic protein. Other examples of genes showing various combinations of essential domains are shown in [Figure 2C](#fig2){ref-type="fig"}.

We devised an algorithm to score genes according to their likelihood of bearing transposon-tolerant and -intolerant regions ([Source code 2](#SD5-data){ref-type="supplementary-material"}). In short, we computed for each CDS the longest interval between five adjacent transposons, multiplied it by the total number of transposons mapping in this CDS, and divided the result by the CDS length. We additionally imposed the following criteria: the interval must be at least 300 bp, must represent more than 10% and less than 90% of the CDS length, and a minimum of 20 transposons must map anywhere within the CDS. \~1200 genes fulfilled these requirements ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), of which the 400 best-scoring ones showed clear domain boundaries ([Figure 2---figure supplements 2](#fig2s2){ref-type="fig"}--[5](#fig2s5){ref-type="fig"}). Essential subdomains are only expected in essential genes and indeed, this gene set was overwhelmingly enriched for previously-annotated essential genes ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}).

Thus, our method allows to identify not only genes, but also subdomains that are important for growth, yielding valuable structure-function information about their cognate proteins.

Comparison of independent libraries reveals genetic interactions {#s2-6}
----------------------------------------------------------------

Our approach can easily identify essential genes and essential protein domains. In addition, its ease makes it a potential tool to uncover genes that are not essential in standard conditions but become important in specific conditions. Indeed, our approach yields two measures --- the number of transposons mapping to a given gene, and the corresponding numbers of sequencing reads. Since in most cases, transposon insertion obliterates the gene function, both measures may be used as a proxy for fitness. We assessed the usefulness of these metrics in various genetic screens.

Synthetic genetic interaction screening is an extremely powerful approach to establish networks of functional connections between genes and biological pathways, and to discover new protein complexes ([@bib12]; [@bib44]). We have recently identified single amino-acid substitutions in the endosomal protein Vps13 that suppress the growth defect of mutants of the ER-mitochondria encounter structure (ERMES) ([@bib31]). Suppression is dependent on the proper function of the mitochondrial protein Mcp1 ([@bib48]) and on the endosomal protein Vam6/Vps39 ([@bib15]; [@bib24]). We generated a transposon library from a strain bearing both the *VPS13* suppressor allele *VPS13(D716H)* and a deletion of the ERMES component *MMM1*. In these conditions, we expected *VPS13*, *MCP1* and *VAM6*/*VPS39* to become indispensable, while ERMES components (*MDM10*, *MDM12* and *MDM34*) should become dispensable.

[Figure 4A](#fig4){ref-type="fig"} shows, for each of the 6603 yeast CDSs, the number of transposon insertion sites mapped in the wild-type (x-axis) and in the *mmm1Δ VPS13(D716H)* library (y-axis). Most CDSs fall on a diagonal, meaning that they were equally transposon-tolerant in both libraries. Consistent with the ERMES suppressor phenotype of the *VPS13(D716H)* mutation, ERMES components fell above the diagonal (that is, they bore more transposons in the *mmm1Δ VPS13(D716H)* than in the wild-type library, [Figure 4A--B](#fig4){ref-type="fig"}). By contrast, *VPS13*, *MCP1* and *VAM6/VPS39* fell under the diagonal, as expected ([@bib30], [Figure 4A, C](#fig4){ref-type="fig"}). Many other genes known to display synthetic sick or lethal interaction with *mmm1Δ* ([@bib23]) were also found, including *TOM70, VPS41, YPT7, VMS1* and *YME1* ([Figure 4A, C](#fig4){ref-type="fig"}).10.7554/eLife.23570.015Figure 4.Genetic interaction analyses.Libraries in panels B, C, E and G are displayed in the same order as in [Figure 1C](#fig1){ref-type="fig"}. (**A**) Comparison of the number of transposons inserted in each of the 6603 yeast CDSs in the wild-type (x-axis) and *mmm1Δ VPS13(D716H)* (y-axis) libraries. (**B**) Transposon coverage of genes encoding ERMES components is increased in libraries from strains bearing the *VPS13(D716H)* allele. (**C**) Examples of genes showing synthetic sick/lethal interaction with *mmm1Δ VPS13(D716H)*. (**D**) Comparison of the number of transposons inserted in each of the 6603 yeast CDSs in the wild-type (x-axis) and *dpl1Δ* (y-axis) libraries. (**E**) Transposon coverage of the *HIP1* locus in the *dpl1Δ his3Δ* library and in all the other libraries (*HIS3*). (**F**) Comparison of the number of transposons inserted in each of the 6603 yeast CDSs in the *dpl1Δ* (x-axis) and *dpl1Δ psd2Δ* (y-axis) libraries. (**G**) Transposon coverage of the *PSD1* locus in the *dpl1Δ psd2Δ* and in all other libraries.**DOI:** [http://dx.doi.org/10.7554/eLife.23570.015](10.7554/eLife.23570.015)10.7554/eLife.23570.016Figure 4---figure supplement 1.Volcano plots comparing libraries or combinations of libraries as indicated.The calculated fold-change in transposon density between the two sets of libraries is plotted in log~2~ scale on the x-axis. The -log~10~(*p*-value) (computed using the Student's t-test) is plotted on the y-axis. ^(1)^The *VPS13(D716H)* and the *mmm1Δ VPS13(D716H)* strains were generated in a *MET17* background while all other libraries where generated in a *met17Δ* background. As a result *MET17* and the overlapping ORF *YLR302C* appear as transposon free in the reference set. *MET6* is more targeted by transposons in *met17Δ* libraries, likely because Met17 produces homocysteine, which needs to be converted to methionine by Met6, or might otherwise accumulate to toxic levels. ^(2)^The *VPS13(D716H)* and *mmm1Δ VPS13(D716H) s*trains were generated in a Matα background, while the others were generated in a Mata background. ^(3)^*YGR190C* overlaps with *HIP1.* ^(4)^*GPP1* shows synthetic lethality with a recessive Mendelian variant present in the *psd2Δ dpl1Δ* strain. However, this variant is neither linked to *DPL1* nor to *PSD2* (data not shown). ^(5)^ERMES component genes scores very high with respect to fold change, because two of the five libraries in the reference set bear the *VPS13(D716H)* allele. The *p-*value, by contrast, is not significant.**DOI:** [http://dx.doi.org/10.7554/eLife.23570.016](10.7554/eLife.23570.016)

As a second proof-of-principle, we generated a library from a strain in which the dihydrosphingosine phosphate lyase gene *DPL1* ([@bib42]) was deleted, and another library from a strain in which both *DPL1* and the phosphatidylserine decarboxylase 2 gene *PSD2* ([@bib50]) were deleted ([Figure 4D,F](#fig4){ref-type="fig"}). In this latter double-deleted strain, phosphatidylethanolamine can only be generated via the mitochondrial phosphatidylserine decarboxylase Psd1, and thus any gene required for lipid shuttling to and from mitochondria should become indispensable ([@bib6]).

*LCB3*, which displays synthetic sick interaction with *DPL1* ([@bib58]), was less transposon-tolerant in both the *dpl1Δ* and the *dpl1Δ psd2Δ* libraries ([Figure 4D](#fig4){ref-type="fig"}). By contrast *PSD1*, which displays a synthetic lethality with *PSD2* on media lacking choline and ethanolamine ([@bib6]), was transposon-intolerant in the *dpl1Δ psd2Δ* library only ([Figure 4F--G](#fig4){ref-type="fig"}). Interestingly, we also found that *VPS13* was less transposon-tolerant in the *dpl1Δ psd2Δ*, consistent with a role for Vps13 in interorganelle lipid exchange ([@bib1]; [@bib29]; [@bib30], [@bib31]).

Additionally, when comparing the *dpl1Δ* and wild-type libraries, one of the best hits was the histidine permease *HIP1* ([Figure 4D--E](#fig4){ref-type="fig"}). This did not, however, reflect a genetic interaction between *HIP1* and *DPL1*, but instead between *HIP1* and *HIS3*; during the construction of the strains, *ADE2* was replaced by a *HIS3* cassette in the wild-type strain, while it was replaced by a NAT cassette in the *dpl1Δ* strain. The histidine-auxotroph *dpl1Δ* strain, therefore required the Hip1 permease to import histidine.

Thus, synthetic genetic interactions are visible through pairwise comparison of the number of transposons per genes. However, this metrics leads to a significant spread of the diagonal ([Figure 4A,D,F](#fig4){ref-type="fig"}). This spread is due to the intrinsic noise of the experiment. Indeed, the number of transposons per gene is expected, for each gene, to follow a binomial distribution. Sampling variability may thus mask biologically relevant differences. To overcome this limitation, we reasoned that comparing sets of one or more libraries against each other, rather than comparing two libraries in a pairwise fashion (as in [Figure 4](#fig4){ref-type="fig"}), would greatly improve the signal-to-noise ratio. We thus calculated an average fold-change of the number of transposons per gene between the experimental and reference sets, as well as a *p*-value (based on a Student's t-test) associated with this change. The fold-change and *p*-values were then plotted as a volcano plot ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}, [Supplementary file 3](#SD3-data){ref-type="supplementary-material"}). In volcano plots, synthetic genes appeared well separated from the bulk of neutral genes, showing that parallel library comparison is a robust way to increase the signal-to-noise ratio.

Synthetic lethality is one type of genetic interaction. Another type is rescue of lethal phenotype, where a gene deletion is lethal in an otherwise wild-type strain but can be rescued by a suppressor mutation. We describe two such phenomena observed in our libraries. The first concerns the septin gene *CDC10*. Septin proteins are cytoskeletal GTPases that form a ring at the bud neck. This structure is necessary for vegetative growth in *S. cerevisiae*, and all septin genes are essential with the exception of *CDC10* ([@bib3]; [@bib38]). Indeed, at low temperature, *cdc10Δ* cells are viable and able to assemble a septin ring. This Cdc10-less ring is based on a Cdc3-Cdc3 interaction, instead of the normal Cdc3-Cdc10 interaction ([@bib38]). Because the propensity of Cdc3 to self-assemble is weak, low temperature is thought to be necessary to stabilize the interaction. Since we grew all libraries at moderately high temperature (30°C), *CDC10* was, as expected, essentially transposon-free in most libraries ([Figure 5A](#fig5){ref-type="fig"}). In the *dpl1Δ psd2Δ* library, however, the number of transposons mapping within *CDC10* increased significantly, indicating that the absence of Psd2 and Dpl1 suppressed the *cdc10Δ* phenotype ([Figure 5A](#fig5){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}, bottom left). Genetic analysis revealed that the *dpl1Δ* allele alone allowed *cdc10Δ* cells to grow at higher temperature, indicating that the Cdc10-less septin ring was stabilized in the absence of Dpl1 ([Figure 5B--C](#fig5){ref-type="fig"}). Genetic analysis also demonstrated that the rescue of *cdc10Δ* by *dpl1Δ* was independent of *PSD2*. It is unclear why the suppressive effect was detected in the *dpl1Δ psd2Δ* library, but not in the *dpl1Δ* library. We speculate that differences in growth conditions between experiments have obscured either the suppression in the *dpl1Δ* library or the involvement of Psd2 in our tetrad analyses.10.7554/eLife.23570.017Figure 5.Synthetic rescue of lethal phenotypes.(**A**) Transposon coverage of *CDC10* in the seven libraries. The coverage is increased in the *dpl1Δ psd2Δ* library. (**B**) Tetrad dissection of a *PSD2/psd2Δ DPL1/dpl1Δ CDC10/cdc10Δ* triple heterozygote at 30°C (left) and 25°C (right). The *cdc10Δ* spores of ascertained genotype are circled with a color-coded solid line. *cdc10Δ* spores for which the genotype can be inferred from the other spores of the tetrad are circled with a color-coded dashed line. (**C**) Quantification of growing and non-growing *cdc10Δ* spores of the indicated genotype obtained from 48 tetrads (three independent diploids). (**D**) Transposon coverage of *DNA2* in the seven libraries. The coverage is increased in the *YEN1^on^* library. (**E**) Tetrad dissection of a *DNA2/dna2Δ YEN1/YEN1* single heterozygote and of a *DNA2/dna2Δ YEN1/YEN1^on^* double heterozygote at 30°C (left) and 25°C (right). All viable *dna2Δ* spores additionally carry the *YEN1^on^* allele (red circle). (**F**) FACS profile of propidium-iodide-stained DNA content in *DNA2* and *dna2Δ YEN1^on^* strains exponentially growing at 30°C (left) and 25°C (right). For *DNA2* panels, each profile is an overlay of two independent strains. For *dna2Δ YEN1^on^* panels, each profile is an overlay of four independent strains.**DOI:** [http://dx.doi.org/10.7554/eLife.23570.017](10.7554/eLife.23570.017)

Dpl1 is an ER protein that does not contact any of the septin subunits; its destabilizing effect on the septin ring must therefore be indirect. Since Dpl1 is a regulator of sphingolipid precursors ([@bib42]) and since the septin ring assembles in contact with the plasma membrane ([@bib4]), it is most likely the changing properties of the membrane in *DPL1*-deficient cells that allow or restrict the assembly of Cdc10-less septin rings. This hypothesis is particularly appealing because temperature has a profound effect on membrane fluidity and composition ([@bib16]). Thus, the stabilizing effect of low temperature on Cdc10-less septin rings might not only be the result of a direct stabilization of Cdc3-Cdc3 interaction, but also of changes in plasma membrane properties, which can be mimicked by *DPL1* ablation.

The second example of rescue of a lethal phenotype was observed in a library made from a strain expressing a constitutively active version of the Holliday-junction resolvase Yen1, a member of the Xeroderma Pigmentosum G (XPG) family of 5'-flap endonucleases ([@bib25]). In wild-type strains, Yen1 is kept inactive during the S-phase of the cell cycle via Cdk-mediated phosphorylation ([@bib37]). Rapid dephosphorylation at anaphase activates Yen1 for the last stages of mitosis. When nine Cdk1 target sites are mutated to alanine, Yen1 becomes refractory to inhibitory phosphorylation and active during S-phase (Yen1^on^) ([@bib7]). To investigate the cellular consequence of a constitutively active Yen1, we generated a library in a *YEN1^on^* background. We discovered that, under these conditions, the essential gene *DNA2* became tolerant to transposon insertion ([Figure 5D](#fig5){ref-type="fig"}). Further genetic analyses confirmed that the presence of the *YEN1^on^* allele led to a rescue of the lethal phenotype of *dna2Δ* strains; spores bearing the *dna2* deletion failed to grow unless they additionally bore the *YEN1^on^* allele ([Figure 5E](#fig5){ref-type="fig"}). Moreover, at 25°C, the colony size of *dna2Δ YEN1^on^* spores was comparable to that of the *DNA2* counterparts ([Figure 5E](#fig5){ref-type="fig"}, right). However, FACS analysis of DNA content revealed that *dna2Δ YEN1^on^* cells accumulated in S- and G2-phases ([Figure 5F](#fig5){ref-type="fig"}).

*DNA2* encodes a large protein with both helicase and endonuclease activities ([@bib9]). Interestingly, while the helicase activity can be disrupted without affecting yeast viability, the nuclease activity is essential ([@bib59]), presumably due to its involvement in processing long 5'-flaps of Okazaki fragments. Our genetic data now reveal that Yen1 is able to partially fulfill the essential roles of Dna2, provided that its activity is unrestrained in S-phase. Since the spectrum of Yen1 substrates includes 5'-flap structures ([@bib25]), Yen1^on^ may be able to substitute the essential function of Dna2 by providing 5'-flap nuclease activity in S-phase. This finding extends previous work showing that Yen1 serves as a backup for the resolution of replication intermediates that arise in helicase-defective mutants of Dna2 ([@bib59]).

Thus, our method can be used to screen for negative and positive genetic interactions in a rapid, labor-efficient and genome-wide manner, in strains bearing single and multiple mutations.

Chemical genetics approach {#s2-7}
--------------------------

To assess our method's ability to uncover drug targets, we used the well-characterized immune-suppressive macrolide rapamycin. Rapamycin blocks cell proliferation by inhibiting the target of rapamycin complex I (TORC1), through binding to the Fk506-sensitive Proline Rotamase Fpr1 ([@bib22]). The TORC1 complex integrates nutrient-sensing pathways and regulates cellular growth accordingly. Rapamycin treatment therefore elicits a starvation response, which stops proliferation. We generated and harvested a wild-type library, then grew it in medium containing rapamycin at low concentration. To compare it to an untreated wild-type library, we counted the number of sequencing reads mapping to each of the 6603 yeast CDSs in both conditions ([Figure 6A](#fig6){ref-type="fig"}). Most genes fell on a diagonal, as they do not influence growth on rapamycin. By contrast, a few genes were robustly covered by sequencing reads in the rapamycin-treated library, indicating that their interruption conferred rapamycin resistance. Expectedly, the best hit was *FPR1*, encoding the receptor for rapamycin ([@bib21]). Other hits included *RRD1* (Rapamycin-Resistant Deletion 1), *TIP41*, *GLN3*, *SAP190*, *PSP2*, *CCS1*, *ESL2* and members of the PP2A phosphatase *PPH21* and *PPM1* ([Figure 6A](#fig6){ref-type="fig"}). These genes are either directly involved in rapamycin signaling or known to confer rapamycin resistance upon deletion ([@bib57]).10.7554/eLife.23570.018Figure 6.Detection of rapamycin resistant strains.(**A**) Comparison of the number of sequencing reads mapping to each of the 6603 yeast CDSs in rapamycin-untreated (x-axis) and -treated (y-axis) libraries. Note the difference in scale between both axis due to the high representation of rapamycin-resistant clones. (**B**) Distribution of transposons and number of associated sequencing reads on the *PIB2* gene. Transposons with high number of sequencing reads in the rapamycin-treated library are clustered at the 5'-end of the CDS. (**C**) Wild-type (WT) and *pib2Δ* strains were transformed with either an empty plasmid (∅) or plasmids encoding full-length (FL) or indicated fragments of Pib2 (see E, numbers refer to the amino acid position in the full-length Pib2 protein). 5-fold serial dilutions of these strains were spotted on YPD or YPD containing 10 ng/ml rapamycin. Centromeric plasmids were used in all strains, except in those denoted with 2 µ, which carried multi-copy plasmids. (**D**) Strains of the indicated genotypes, transformed with either an empty plasmid (∅) or plasmids encoding full length (*pPIB2*) or truncated (*pPIB2^165-635^*) versions of Pib2, were grown exponentially in minimal medium with proline as nitrogen source. 3 mM glutamine was added to the culture and the cells were harvested 2 min later. Protein extracts were resolved on an SDS-page and probed with antibodies either specific for Sch9-pThr^737^ (P-Sch9), or for total Sch9 to assess TORC1 activity. (**E**) Schematic overview of Pib2 architecture and of the fragments used for genetic studies. (**F**) Summary of yeast-two-hybrid interactions between Pib2 fragments and the TORC1 subunit Kog1 ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Fragments indicated by a black box interacted with Kog1, fragments indicated by a white box did not. (**G**) *pib2Δ* cells expressing the indicated Pib2 fragments from plasmids (see E) were assayed for their sensitivity to rapamycin (2.5 or 5 ng/ml) as in C. (**H**) WT or *pib2Δ* cells expressing the indicated Pib2 fragments from plasmids were assayed as in G, except that cells were spotted on synthetic medium to apply a selective pressure for plasmid maintenance.**DOI:** [http://dx.doi.org/10.7554/eLife.23570.018](10.7554/eLife.23570.018)10.7554/eLife.23570.019Figure 6---figure supplement 1.**A**) Transposon coverage of the *PIB2* gene.Top row is the rapamycin-treated library and rows below are presented as in [Figures 2](#fig2){ref-type="fig"}--[5](#fig5){ref-type="fig"}. The gray scale has been adjusted to account for the large number of sequencing reads mapping in the 5' region of the gene. (**B**) Yeast-two-hybrid assay assessing the interaction of the indicated Pib2 fragments encoded on the pCAB plasmid, with full-length Kog1 encoded on the pPR3N plasmid. (**C**) *gtr1Δ gtr2Δ* cells expressing indicated, plasmid-encoded Pib2 fragments (see [Figure 6E](#fig6){ref-type="fig"}) were assayed for their sensitivity to rapamycin. Note that expressing Pib2^Δ533-620^ in *gtr1Δ gtr2Δ* cells appears to inhibit growth even in the absence of rapamycin. (**D**) *gtr1Δ gtr2Δ* cells, transformed with centromeric plasmids expressing Pib2 fragments (see [Figure 6E](#fig6){ref-type="fig"}) and alleles of Gtr1 and Gtr2 as indicated, were assayed for their sensitivity to rapamycin.**DOI:** [http://dx.doi.org/10.7554/eLife.23570.019](10.7554/eLife.23570.019)

Finding the TORC1 regulator *PIB2* ([@bib28]) was however unexpected, because *PIB2* deletion confers sensitivity, not resistance, to rapamycin ([@bib28]; [@bib39]). To solve this conundrum, we looked at the distribution of transposons on the *PIB2* coding sequence. All the insertions selected by rapamycin treatment mapped to the 5'-end of the gene ([Figure 6B](#fig6){ref-type="fig"}). On the contrary, the rest of *PIB2* was less covered in the rapamycin-treated than in non-rapamycin-treated libraries ([Figure 6---figure supplement 1A](#fig6s1){ref-type="fig"}). Insertions in the 5' end of *PIB2* therefore conferred rapamycin resistance, while insertions elsewhere, like complete deletion of *PIB2*, conferred rapamycin sensitivity.

To confirm this result, we engineered N-terminal truncations of Pib2, guided by the transposon map. Strains expressing Pib2 variants that were truncated from the first until up to amino acid 304 were hyperresistant to rapamycin ([Figure 6C](#fig6){ref-type="fig"}, top). We also confirmed that, by contrast, complete *PIB2* deletion caused rapamycin hypersensitivity. A larger N-terminal truncation extending beyond the mapped territory of rapamycin resistance-conferring transposons, did not mediate hyperresistance to rapamycin ([Figure 6G](#fig6){ref-type="fig"}, Pib2^426-635^).

To assess whether rapamycin-hyperresistant *PIB2* truncations behaved as gain-of-function alleles, we co-expressed Pib2^165-635^ and full-length Pib2. In these conditions, the rapamycin hyperresistance was mitigated, indicating that the effect of the truncated Pib2 protein was semi-dominant ([Figure 6C](#fig6){ref-type="fig"}, bottom). Expressing the truncation from a high-copy (2 µ) vector did not further increase resistance to rapamycin, indicating that higher expression levels did not change the semi-dominance of the *PIB2* truncation allele.

Thus, Pib2 truncation leads to a gain-of-function that translates into semi-dominant rapamycin hyperresistance. Because gain-of-function alleles of *PIB2* lead to rapamycin resistance, while loss-of-function alleles lead to sensitivity, our data suggest that Pib2 positively regulates TORC1 function. To test this idea further, we investigated the effects of full-length and various truncations of Pib2 on TORC1 signaling. Switching yeast cells from a poor nitrogen source (proline) to a rich one (glutamine) triggers a fast activation of TORC1 ([@bib47]), leading to a transient surge in the phosphorylation of Sch9, a key target of TORC1 in yeast ([@bib51]). We cultured cells on proline-containing medium and studied TORC1 activation 2 min following addition of 3 mM glutamine by determining the phosphorylation levels of Sch9-Thr^737^. Pib2 deficiency severely blunted TORC1 activation in these conditions ([Figure 6D](#fig6){ref-type="fig"}, top). In a control experiment, a strain lacking *GTR1* -- a component of the TORC1-activating EGO (Exit from rapamycin-induced GrOwth arrest) complex, which is orthologous to the mammalian Rag GTPase-Ragulator complex ([@bib10]; [@bib40]) -- showed a similarly blunted response with respect to TORC1 activation following glutamine addition to proline-grown cells ([Figure 6D](#fig6){ref-type="fig"}, top). By contrast, glutamine-mediated TORC1 activation appeared normal in a strain expressing an N-terminally truncated Pib2 variant (*pPIB2^165-635^,* [Figure 6D](#fig6){ref-type="fig"}, bottom). Thus, like Gtr1, Pib2 is necessary to activate TORC1 in response to amino acids. The N-terminus of Pib2 appears to be an inhibitory domain. The ablation of this domain confers rapamycin resistance, yet is not sufficient to constitutively activate TORC1 (*e.g.* in proline-grown cells).

Having identified an inhibitory activity at the N-terminus of Pib2, we proceeded to address the function of other Pib2 domains. To this aim, we used a split-ubiquitin-based yeast-two-hybrid assay to probe the interaction of Pib2 fragments with the TORC1 component Kog1, and studied the rapamycin resistance of strains expressing various truncations of Pib2 ([Figure 6E--F](#fig6){ref-type="fig"}). We found that Pib2 harbored at least two central Kog1-binding regions, since two mostly non-overlapping fragments (Pib2^1-312^ and Pib2^304-635^) showed robust interaction with Kog1 ([Figure 6F](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). Kog1 binding is, however, not essential for Pib2-mediated TORC1 activation, since cells expressing a fragment without these Kog1-binding domains (Pib2^426-635^) were as rapamycin-resistant as cells expressing full length Pib2 (FL, [Figure 6G](#fig6){ref-type="fig"}).

Pib2 harbors a phosphatidylinositol-3-phosphate (PI3P) -binding Fab1-YOTB-Vac1-EEA1 (FYVE) domain ([Figure 6E](#fig6){ref-type="fig"}). Pib2 truncations lacking the FYVE domain are unable to bind PI3P, and hence to properly localize to the vacuole ([@bib28]). When cells expressed FYVE domain-truncated Pib2 (Pib2^Δ426-532^), their rapamycin resistance decreased, but not as severely as observed in *pib2Δ* strains ([Figure 6G](#fig6){ref-type="fig"}). This indicates that FYVE-domain-mediated vacuolar recruitment is not absolutely required for Pib2 to activate TORC1.

Strikingly, cells expressing Pib2 variants that were either truncated at the extreme C-terminus (*PIB2^1-620^*) or carried a deletion within the C-terminus (*PIB2^∆^*^533-620^) were as sensitive to rapamycin as *pib2∆* cells ([Figure 6G](#fig6){ref-type="fig"}). The C-terminus of Pib2 is therefore important to ensure proper TORC1 activation.

We conclude that Pib2 harbors the following functional domains: a large N-terminal Inhibitory Domain (NID), and a C-terminal TORC1-Activating Domain (CAD); the central portion of the protein harbors FYVE and Kog1-binding domains for proper targeting of Pib2 to the vacuole and TORC1, respectively.

Could the NID act in an auto-inhibitory allosteric fashion by preventing the CAD from activating TORC1? We reasoned that if this were the case, plasmid-encoded N-terminally truncated Pib2 should confer similar levels of rapamycin resistance independently of whether a genomic wild-type *PIB2* copy was present or not. However, wild-type cells expressing N-terminally truncated Pib2^165-635^ from a centromeric or a multi copy 2 µ plasmid were less resistant to rapamycin than *pib2∆* cells expressing Pib2^165-635^ from a centromeric plasmid ([Figure 6C](#fig6){ref-type="fig"}). Thus, the NID activity of the endogenously-expressed wild-type Pib2 is able to mitigate the rapamycin resistance conferred by ectopic expression (or overexpression) of the CAD. Therefore, our data suggest that the NID does not auto-inhibit the CAD within Pib2, but rather, that the NID and CAD act independently and antagonistically on TORC1.

This latter scenario predicts that, just as expressing NID-truncated Pib2 semi-dominantly activates TORC1 ([Figure 6C](#fig6){ref-type="fig"}), expressing CAD-truncated Pib2 should semi-dominantly inhibit it. To test this prediction, we expressed the two CAD truncations Pib2^Δ533-620^ and Pib2^1-620^ in an otherwise wild-type strain. The resulting strains were significantly more sensitive to rapamycin than their counterparts expressing only full length Pib2 ([Figure 6H](#fig6){ref-type="fig"}). Furthermore, when *pib2Δ* cells expressed the Pib2 CAD truncation alleles, they became even more sensitive to rapamycin. Therefore, Pib2-NID does not act in an auto-inhibitory manner, but rather inhibits TORC1 independently of the presence of a Pib2-CAD.

Since the Rag GTPase Gtr1-Gtr2 module of the EGO complex also mediates amino acid signals to TORC1 ([@bib5]; [@bib14], see also [Figure 6D](#fig6){ref-type="fig"}), we tested the possibility that Pib2-NID inhibits TORC1 by antagonizing Gtr1-Gtr2. This does not appear to be the case; first, the expression of Pib2^Δ533-620^ or Pib2^1-620^ further enhanced the rapamycin sensitivity of *gtr1Δ gtr2Δ* cells ([Figure 6---figure supplement 1C](#fig6s1){ref-type="fig"}), and second, the Pib2^Δ533-620^- or Pib2^1-620^-mediated rapamycin hypersensitivity was not suppressed by expression of the constitutively active, TORC1-activating Gtr1^Q65L^-Gtr2^S23L^ module ([@bib5]; [Figure 6---figure supplement 1D](#fig6s1){ref-type="fig"}). These results suggest that Pib2-NID inhibits TORC1 independently of the EGO complex.

In summary, Pib2 is targeted to TORC1 by binding to the vacuolar membrane through its FYVE domain and to Kog1 via its middle portion. Pib2 harbors two antagonistic activities, one activating and the other repressing TORC1. The dose-independent semi-dominant nature of the respective truncations indicates that both repressing and activating activities influence TORC1 independently and do not appear to compete for the same sites on TORC1.

We speculate that high-quality amino acids, such as glutamine, balance the antagonistic TORC1-activating and -repressing activities of Pib2 to tune growth rate according to available resources. In this context, it will be interesting to elucidate how the activities of Pib2 and the EGO complex are coordinated to stimulate TORC1 in response to amino acids.

Discussion {#s3}
==========

Here we present a novel method based on random transposon insertion and next-generation sequencing, to functionally screen the genome of *Saccharomyces cerevisiae*. SAturated Transposon Analysis in Yeast (SATAY) can reveal positive and negative genetic interactions, auxotrophies, drug-sensitive or -resistant mutants, and map functional protein domains. SATAY combines advantages from both classical genetics and high-throughput robotic screens. SATAY can in principle be implemented in any strain background, since it does not rely on the existence of available deletion libraries and does not necessitate markers to follow genetic traits. Moreover, SATAY explores a wide genetic space; exotic alleles can be generated as exemplified by *PIB2* ([Figure 6](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}), where transposon insertions in different regions of the gene generate opposite phenotypes. Transposon insertion is not limited to CDSs; we observe that promoters of essential genes are often transposon-intolerant ([Figure 2](#fig2){ref-type="fig"}, see *GAL10, SGV1, MMS21, RET2, HRR25, NPA3, SEC9, SWI1).* We also observe that known essential tRNA, snRNA, as well as SRP RNA genes are transposon intolerant (see Supplementary Dataset). Finally, our data reveal transposon-intolerant areas of the genome that do not correspond to any annotated feature, indicating that SATAY could help discover yet-unknown functional elements.

SATAY yields unprecedented insight on the domain structure-function relationship of important proteins, and allows the mapping of important functional domains, without prior knowledge. Dispensable domains in essential proteins might not be required for the essential function of these proteins, but may have other roles. The sub-gene resolution enabled by SATAY may thus unveil yet-unsuspected accessory or regulatory functions, even in otherwise well-studied proteins. In addition, structure-function information revealed by SATAY may guide 3D-structure determination efforts by indicating possibly flexible accessory domains.

The resolution of a SATAY screen is directly proportional to the number of transposons mapped onto the genome. The current resolution is \~1/40 bp, which is amply sufficient to confidently identify essential genes and protein domains. This resolution is achieved by mapping \~300,000 transposons, starting from a 1.6E6-colonies library. Not every colony generates a detectable transposon. This is due to several reasons. (1) Excised transposons only reinsert in 60% of the cases (our observations and [@bib33]). (2) 7% of the sequencing reads mapped onto repetitive DNA elements (such as rDNA, Ty-elements and subtelomeric repeats) and were discarded because of ambiguous mapping. (3) Two transposons inserted in the same orientation within two bp of each other will be considered as one by our algorithm. This might be exacerbated at densely covered areas of the genome, such as pericentromeric regions. (4) Some transposon insertion products may not be readily amplifiable by our PCR approach.

We observe that increasing both the size of the original library and the sequencing depth leads to an increase in mapped transposon number (albeit non-proportional, [Table 1](#tbl1){ref-type="table"}). Therefore, the resolution of a screen can be tailored according to the question and the available resource.

We could not detect a preferred sequence for transposon insertion ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}), yet two features of the yeast genome biased insertion frequency in select regions. The first is nucleosome position; the Ds transposon has a tendency to insert more frequently within inter-nucleosomal regions, indicating that, like other transposases ([@bib17]), Ac might have better access to naked DNA ([Figure 1---figure supplement 2B--C](#fig1s2){ref-type="fig"}). The second pertains to a tendency of the transposon to integrate in the spatial proximity of its original location ([@bib33]). Indeed, when originated from a centromeric plasmid, the transposon has an increased propensity to reinsert in the pericentromeric regions of other chromosomes. This is not due to a particular feature of pericentromeric chromatin, since this propensity is lost when the transposon original location is on the long arm of ChrXV ([Figure 1B](#fig1){ref-type="fig"}). Instead, the increased propensity is likely resulting from the clustering of centromeres in the nuclear space ([@bib27]), indicating that centromeric plasmids cluster with the chromosomal centromeres. Thus, SATAY can be utilized to probe, not only the function of the genome, but also its physical and regulatory features, such as nucleosome position and 3D architecture.

Finally, SATAY does not require any particular equipment besides access to a sequencing platform, and involves a limited amount of work. It can be easily multiplexed to perform several genome-wide screens simultaneously. Each screen yields two measures, the number of transposons and the number of sequencing reads, both of which, for each gene, reveal the fitness of the cognate mutant. While the number of transposons per gene is appropriate to look for genes that become important for growth, as in genetic interaction screens, the number of sequencing reads is better suited to identify strains that are positively selected, like drug-resistant mutants. Both metrics suffer from intrinsic noise, stemming from the inherently discrete structure of the data, and probably also from unavoidable biases in the amplification and sequencing of the libraries. We show that this noise can be reduced by comparing multiple libraries against each other ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Moreover, comparing multiple libraries allows to tailor the composition of each library set to needs. For instance, grouping the *VPS13(D716H)* with the *mmm1Δ VPS13(D716H)* libraries allows to selectively detect synthetic interactions with *VPS13(D716H)* (e.g. ERMES components). By contrast, comparing the *mmm1Δ VPS13(D716H)* library with all others, selectively finds genes important for the ERMES suppression phenomenon. Thus, while signal-to-noise ratio might be a limiting factor for the detection of genetic interactions, we anticipate that increasing the number of libraries, for instance by generating multiple libraries in each condition, will likely decrease the incidence of false positive and false negative. With the increasing number of screens performed in various conditions will also come the ability to find correlation patterns among genes that are required or dispensable for growth in similar sets of conditions. Such correlations are accurate predictors of common functions and have been extensively used in synthetic genetic screens, such as the E-MAP procedure ([@bib29]; [@bib44]). However, while E-MAP screens compute patterns of genetic interaction on a subset of chosen genetic interaction partners, SATAY allows to detect genetic interactions at the genome scale.

Because the approach only necessitates a transposon and a transposase, it should not only be feasible in *S. cerevisiae* and *S. pombe* ([@bib20]), but also amenable to other industrially-, medically- or scientifically-relevant haploid fungi, such as* Y. lipolytica*, *C. glabrata, K. lactis* and *P. pastoris*.

The Ds transposon can in principle accommodate extra sequences with no known length limitation ([@bib32]). An interesting future development will be to incorporate functional units in the transposon DNA, for instance strong promoters, repressors or terminators, IRESs, recognition sites for DNA-binding proteins (LacI or TetR), recombination sites (LoxP, FRP), or coding sequences for in-frame fusion, such as GFP, protein- or membrane-binding domains, signal sequences, etc. Improved designs will not only permit finer mapping of protein domains without reliance on spurious transcription and translation, but might allow the exploration of an even wider genetic space, for instance by generating gain-of-function variants, thus enabling the development of novel approaches to interrogate the yeast genome.

Materials and methods {#s4}
=====================

Plasmids and strains {#s4-1}
--------------------

All yeast strains, oligonucleotides and plasmids used herein are listed in [Tables 2](#tbl2){ref-type="table"}, [3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}, respectively. To generate pBK257, the *ADE2* gene interrupted with the MiniDs transposon was PCR amplified from strain CWY1 ([@bib55]), using PCR primers \#4 and \#5. The PCR product and pWL80R_4x (plasmid encoding the Ac transposase under the control of the *GAL1* promoter, [@bib33]) were digested with SacI, then ligated together. This plasmid does not confer adenine prototrophy to *ade2Δ* cells unless the Ac transposase excises the MiniDS transposon, and repairs the *ADE2* gene.10.7554/eLife.23570.020Table 2.Yeast strains used in this study.**DOI:** [http://dx.doi.org/10.7554/eLife.23570.020](10.7554/eLife.23570.020)**NameParentGenotypeReference** CWY1BY4723*MATa his3Δ0 ura3Δ0 ade2:Ds-1*[@bib55] ByK157BY4743*MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 VPS13(D716H)*[@bib31] ByK352BY4741*MATa his3Δ1 leu2Δ0 met17Δ0 ura3Δ0 ade2Δ::HIS3*\*This study ByK484By4742*MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 ade2Δ::HIS3*\*This study ByK485ByK352 and ByK484*MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0/ura3Δ0 ade2Δ::HIS3*\**/ade2Δ::HIS3\**This study ByK446ByK157*MATα his3Δ1 leu2Δ0 ura3Δ0 ade2Δ::HIS3*\* *VPS13(D716H)*This study ByK528ByK446*MATα his3Δ1 leu2Δ0 ura3Δ0 ade2Δ::HIS3*\* *VPS13(D716H) mmm1Δ::KanMX6*This study ByK530ByK352*MATa his3Δ1 leu2Δ0 met17Δ0 ura3Δ0 ade2Δ::NAT*\* *dpl1Δ::KanMX6*This study ByK533ByK352*MATa his3Δ1 leu2Δ0 met17Δ0 ura3Δ0 ade2Δ::HIS3*\* *psd2Δ::KanMX6 dpl1Δ::NAT*This study ByK576ByK485*MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0/ura3Δ0 ade2Δ::HIS3*\**/ade2Δ::HIS3\* prp45Δ::KanMX6/PRP45*This study ByK579ByK485*MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0/ura3Δ0 ade2Δ::HIS3*\**/ade2Δ::HIS3\* PRP45^1-462^-HA(KanMX6)/ PRP45*This study ByK583ByK485*MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0/ura3Δ0 ade2Δ::HIS3*\**/ade2Δ::HIS3\* taf3Δ::KanMX6/TAF3*This study ByK588ByK485*MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0/ura3Δ0 ade2Δ::HIS3*\**/ade2Δ::HIS3\* TAF3^1-270^-HA(KanMX6)/ TAF3*This study ByK725ByK533 and ByK484*MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0/ura3Δ0 ade2Δ::HIS3*\**/ade2Δ::HIS3\* psd2Δ::KanMX6/PSD2 dpl1Δ::NAT /DPL1*This study ByK726ByK533 and ByK484*MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0/ura3Δ0 ade2Δ::HIS3*\**/ade2Δ::HIS3\* psd2Δ::KanMX6/PSD2 dpl1Δ::NAT /DPL1*This study ByK739ByK725*MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0/ura3Δ0 ade2Δ::HIS3*\**/ade2Δ::HIS3\* psd2Δ::KanMX6/PSD2 dpl1Δ::NAT /DPL1 cdc10Δ::URA3/CDC10*This study ByK740ByK726*MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0/ura3Δ0 ade2Δ::HIS3*\**/ade2Δ::HIS3\* psd2Δ::KanMX6/PSD2 dpl1Δ::NAT /DPL1 cdc10Δ::URA3/CDC10*This study ByK741ByK726*MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0 LYS2/lys2Δ0 met17Δ0/MET17 ura3Δ0/ura3Δ0 ade2Δ::HIS3*\**/ade2Δ::HIS3\* psd2Δ::KanMX6/PSD2 dpl1Δ::NAT /DPL1 cdc10Δ::URA3/CDC10*This study YJM3916ByK352*MATa his3Δ1 leu2Δ0 met17Δ0 ura3Δ0 ade2Δ::HIS3*\* *YEN1^on^*This study YL516BY4741/BY4742*MATa his3Δ1 leu2Δ0 ura3Δ0*[@bib5] MB32YL516*MATa his3Δ1 leu2Δ0 ura3Δ0 gtr1Δ::kanMX*[@bib5] RKH106YL516*MATa his3Δ1 leu2Δ0 ura3Δ0 pib2Δ::kanMX*This study RKH241MB32*MATa his3Δ1 leu2Δ0 ura3Δ0 gtr1Δ::kanMX gtr2Δ::hphMX4*This study NMY51\
*his3∆200 trp1-901 leu2-3,112 ade2 LYS::(lexAop)4-HIS3 ura3::(lexAop)8- lacZ ade2::(lexAop)8-ADE2 GAL4*Dualsystems Biotech AG[^3]10.7554/eLife.23570.021Table 3.Oligonucleotides used in this study.**DOI:** [http://dx.doi.org/10.7554/eLife.23570.021](10.7554/eLife.23570.021)**\#Original nameSequencePurpose1**P5_MiniDsAATGATACGGCGACCACCGAGATCTACtccgtcccgcaagttaaataamplify library**2**MiniDs_P7CAAGCAGAAGACGGCATACGAGATacgaaaacgaacgggataaaamplify library**3**688_minidsSEQ1210tttaccgaccgttaccgaccgttttcatccctasequence library**4**ADE2FwdGGTTCGAGCTCCCTTTTGATGCGGAATTGACclone *ADE2* MiniDS**5**ADE2RevGACCTGAGCTCTTACTGGATATGTATGTATGclone *ADE2* MiniDS**6**Ade2PriFwdGTATAAATTGGTGCGTAAAATCGTTGGATCTCTCTTCTAAcggatccccgggttaattaadelete *ADE2***7**Ade2PriRevTATGTATGAAGTCCACATTTGATGTAATCATAACAAAGCCgaattcgagctcgtttaaacdelete *ADE2***8**Dpl1_Janke_S1AGCAAGTAGGCTAGCTTCTGTAAAGGGATTTTTCCATCTAATACAcgtacgctgcaggtcgacdelete *DPL1***9**Dpl1_Janke_S2GCACTCTCGTTCTTTAAATTATGTATGAGATTTGATTCTATATAGatcgatgaattcgagctcgdelete *DPL1***10**Psd2_pringle_FGATGCTGTATCAATTGGTAAAGAATCCTCGATTTTCAGGAGCATCCAACGcgtacgctgcaggtcgacdelete *PSD2***11**Psd2_pringle_RCTTGTTTGTACACGCTATAGTCTATAATAAAGTCTGAGGGAGATTGTTCATGatcgatgaattcgagctcgdelete *PSD2***12**TAF3_R1TGGATGAGATAATGACGAAAGAAAATGCAGAAATGTCGTTgaattcgagctcgtttaaac*TAF3* partial deletion**13**TAF3_aa90_F2AGGTATTGTTAAGCCTACGAACGTTCTGGATGTCTATGATcggatccccgggttaattaaTAF3 partial deletion**14**Taf3_FwdGGCAAGATGTGATCAGGACGcheck *TAF3* partial deletion**15**Taf3_RevTCTTGAAGAAGCGAAAGTACACTcheck *TAF3* partial deletion**16**TAF3_R1TGGATGAGATAATGACGAAAGAAAATGCAGAAATGTCGTTgaattcgagctcgtttaaac*TAF3* complete deletion**17**TAF3_aa1\_\
F1GAAAACAGCGATATCTTTGGGTCAATAGAGTTCCTCTGCTtgaggcgcgccacttctaaa*TAF3* complete deletion**18**PRP45_R1ACTCAAGCACAAGAATGCTTTGTTTTCCTAGTGCTCATCCTGGGCgaattcgagctcgtttaaac*PRP45* partial deletion**19**PRP45_aa154_F2AACGACGAAGTCGTGCCTGTTCTCCATATGGATGGCAGCAATGATcggatccccgggttaattaa*PRP45* partial deletion**20**PRP45_FwdAGGTTGTAGCACCCACAGAAcheck *PRP45* partial deletion**21**PRP45_RevCAATCATCACACCTCAGCGAcheck *PRP45* partial deletion**22**PRP45_R1ACTCAAGCACAAGAATGCTTTGTTTTCCTAGTGCTCATCCTGGGCgaattcgagctcgtttaaac*PRP45* complete deletion**23**PRP45_aa1_F1GCTCTGAGCCGAGAGGACGTATCAGCAACCTCAACCAAATtgaggcgcgccacttctaaa*PRP45* complete deletion**24**CDC10-Ura3_fwdAAGGCCAAGCCCCACGGTTACTACAAGCACTCTATAAATATATTAtgacggtgaaaacctctgac*CDC10* complete deletion**25**URA3-CDC10_revTTCTTAATAACATAAGATATATAATCACCACCATTCTTATGAGATtcctgatgcggtattttctcc*CDC10* complete deletion**26**OJM370ATGGGTGTCTCACAAATATGGGAmplify *YEN1***27**OJM371TTCAATAGTGCTACTGCTATCACAmplify *YEN1***28**OJM372TTCAATAGTGCTACTGCTATCACTGTCACAGGCTCAAACCGGTCGACTG TTCGTACGCTGCAGGTCGAC*Delitto perfetto* on *YEN1***29**OJM373ATGGGTGTCTCACAAATATGGGAATTTTTGAAGCCATATCTGCAAGATTCCCGCGCGTTGGCCGATTCAT*Delitto perfetto* on *YEN1***30**o3958gacggtatcgataagcttgatatcgGCGCTGGCATCTTTAATCTC*PIB2* cloning**31**o3959actagtggatcccccgggctgcaggTGCTTGGATCCTTCTTGGTC*PIB2* cloning**32**o3224TAATA CGACT CACTA TAGGGvarious *PIB2* truncations**33**o3225ATTAA CCCTC ACTAA AGGGA Avarious *PIB2* truncations**34**o4034atctagttcagggttcgacattctggtctccactac*PIB2^165-635^* truncation**35**o4010gtagtggagaccagaatgtcgaaccctgaactagat*PIB2^165-635^* truncation**36**o4012tagtggagaccagaatgttaccgcagcctgct*PIB2^304-635^* truncation**37**o4035tcaaattagaactagcattcattctggtctccactacaactgtg*PIB2^221-635^* truncation**38**o4011cacagttgtagtggagaccagaatgaatgctagttctaatttga*PIB2^221-635^* truncation**39**o4062atagttggtattaagttgattctcattctggtctccactacaactg*PIB2^426-635^* truncation**40**o3996cagttgtagtggagaccagaatgagaatcaacttaataccaactat*PIB2^426-635^* truncation**41**o4063cgtgtttgcgttatggttgtcgctgttcggaataga*PIB2^Δ426-532^* truncation**42**o3997tctattccgaacagcgacaaccataacgcaaacacg*PIB2^Δ426-532^* truncation**43**o4064cacagagccgataacactcgtggttgaaaggttctc*PIB2^Δ533-620^* truncation**44**o3998gagaacctttcaaccacgagtgttatcggctctgtg*PIB2^Δ533-620^* truncation**45**o4065gtctcgcaaaaaatgttcatcagcccaaaacatcattaccttct*PIB2^1-620^* truncation**46**o3999agaaggtaatgatgttttgggctgatgaacattttttgcgagac*PIB2^1-620^* truncation**47**o1440GCTAGAGCGGCCATTACGGCCCCGGAGATTTATGGACCTC*KOG1* cloning into pPR3N**48**o1442CGATCTCGGGCCGAGGCGGCCTCAAAAATAATCAATTCTCTCGTC*KOG1* cloning into pPR3N**49**o3787GCTAGAGCGGCCATTACGGCC GAATTGTACAAATCTAGAACTAGTcloning *PIB2* fragments into pCabWT\***50**o3788CGATCTCGGGCCGAGGCGGCCAA GAAACTACTCCAATTCCAGTTTGCcloning *PIB2* fragments into pCabWT\***51**o3872CGATCTCGGGCCGAGGCGGCCAAGCCCAAAACATCATTACCTTCTTCTcloning *PIB2* fragments into pCabWT\***52**o3871CGATCTCGGGCCGAGGCGGCCAAATCTTCGCCCTCCTCAACGTcloning *PIB2* fragments into pCabWT\***53**o3870CGATCTCGGGCCGAGGCGGCCAAGTTGATTCTGTCGCTGTTCGcloning *PIB2* fragments into pCabWT\***54**o3933GCTAGAGCGGCCATTACGGCCAGGAAGAAATTACGCAATTACTACcloning *PIB2* fragments into pCabWT\***55**o3934GCTAGAGCGGCCATTACGGCC AGTGTTATCGGCTCTGTGCCcloning *PIB2* fragments into pCabWT\***56**o3868CGATCTCGGGCCGAGGCGGCCAAATTAGTGCTCGAAGCAGGCTcloning *PIB2* fragments into pCabWT\***57**o3867CGATCTCGGGCCGAGGCGGCCAAGTCATCCGTGAATGGCAACGcloning *PIB2* fragments into pCabWT\***58**o3866CGATCTCGGGCCGAGGCGGCCAAGCCTGCCCCTGTTGAGCTCTcloning *PIB2* fragments into pCabWT\***59**o3865CGATCTCGGGCCGAGGCGGCCAAGTCAGCACCGCTTTCCTCATcloning *PIB2* fragments into pCabWT\*[^4]10.7554/eLife.23570.022Table 4.Plasmids used in this study.**DOI:** [http://dx.doi.org/10.7554/eLife.23570.022](10.7554/eLife.23570.022)**NameParentDescriptionReference** pBK257pWL80R_4xCEN/*URA3*, carries MiniDs in *ADE2* and hyperactive Ac transposase under *GAL1* promoterThis study pWL80R_4x\
CEN/*URA3*, carries hyperactive Ac transposase under *GAL1* promoter[@bib33] pCORE-UH\
*Delitto pefetto URA3* cassette[@bib46] pJM7\
pENTRY-*YEN1^ON^*This study pRS413\
*CEN/HIS3*, empty vector[@bib45] pRS415\
*CEN/LEU2*, empty vector[@bib45] pRS416\
*CEN/URA3*, empty vector[@bib45] p1822pRS413*CEN/HIS3*, *GTR1*This study p1451pRS415*CEN/LEU2*, *GTR2*This study p1821pRS413*CEN/HIS3*, *GTR1^Q65L^*This study p1452pRS415*CEN/LEU2*, *GTR2^S23L^*This study p3084pRS416*CEN/URA3*, *PIB2*This study p3099p3084*CEN/URA3*, *PIB2^165-635^*This study p3097p3084*CEN/URA3*, *PIB2^304-635^*This study p3101p3084*CEN/URA3*, *PIB2^221-635^*This study p3253pRS426*2 μ/URA3*, *PIB2*This study p3255pRS426*2 μ/URA3*, *PIB2^165-635^*This study p3163p3084*CEN/URA3*, *PIB2^426-635^*This study p3153p3084*CEN/URA3*, *PIB2^Δ426-532^*This study p3154p3084*CEN/URA3*, *PIB2^Δ533-620^*This study p3156p3084*CEN/URA3*, *PIB2^1-620^*This study pPR3N\
*2 μ/TRP1*, *NubG-HA*Dualsystems Biotech AG pCabWT\
*CEN/LEU2*, *Aβ-Cub-LexA-VP16*Dualsystems Biotech AG p3081pPR3N*2 μ/TRP1*, *NubG-HA-KOG1*This study p2966pCabWT*CEN/LEU2*, *Aβ-PIB2-Cub-LexA-VP16*This study p3002pCabWT*CEN/LEU2*, *Aβ-PIB2^1-620^-Cub-LexA-VP16*This study p3007pCabWT*CEN/LEU2*, *Aβ-PIB2^1-550^-Cub-LexA-VP16*This study p3001pCabWT*CEN/LEU2*, *Aβ-PIB2^1-428^-Cub-LexA-VP16*This study p3051pCabWT*CEN/LEU2*, *Aβ-PIB2^440-550^-Cub-LexA-VP16*This study p3054pCabWT*CEN/LEU2*, *Aβ-PIB2^556-620^-Cub-LexA-VP16*This study p3052pCabWT*CEN/LEU2*, *Aβ-PIB2^621-635^-Cub-LexA-VP16*This study p3000pCabWT*CEN/LEU2*, *Aβ-PIB2^1-312^-Cub-LexA-VP16*This study p2987pCabWT*CEN/LEU2*, *Aβ-PIB2^304-635^-Cub-LexA-VP16*This study p2999pCabWT*CEN/LEU2*, *Aβ-PIB2^1-162^-Cub-LexA-VP16*This study p2986pCabWT*CEN/LEU2*, *Aβ-PIB2^165-635^-Cub-LexA-VP16*This study p2998pCabWT*CEN/LEU2*, *Aβ-PIB2^1-101^-Cub-LexA-VP16*This study p2991pCabWT*CEN/LEU2*, *Aβ-PIB2^102-635^-Cub-LexA-VP16*This study p2997pCabWT*CEN/LEU2*, *Aβ-PIB2^1-49^-Cub-LexA-VP16*This study p2990pCabWT*CEN/LEU2*, *Aβ-PIB2^50-635^-Cub-LexA-VP16*This study

Deletion strains were generated by PCR-mediated gene replacement using the Longtine toolbox for *KanMX6* and *HIS3* replacement ([@bib35]) and the Janke toolbox for *NATnt2* ([@bib26]), with primers listed in [Table 3](#tbl3){ref-type="table"}. Strain YJM3916 carrying *YEN1^ON^* at the endogenous locus was generated using the *delitto perfetto* method ([@bib46]).

Library generation {#s4-2}
------------------

*ade2Δ* strains were transformed with the pBK257 plasmid. These strains are phenotypically *ade*-, since the *ADE2* gene borne on the plasmid is interrupted by the MiniDs transposon. One liter of freshly prepared SD -Ura +2% Raffinose +0.2% Dextrose is inoculated with *ade2Δ* cells freshly transformed with pBK257, directly scraped off the transformation plates, at a final OD600 = 0.15. The culture is grown to saturation for 18 to 24 hr at 30°C. Cells are spun for 5 min at 600x g, 20°C, and resuspended in their supernatant at a final OD600 = 39. 200 μl of this resuspension are plated on \~250--300×8.5 cm plates containing 25 ml of SD +2% Galactose -Adenine using glass beads. Plates are incubated in closed but not sealed plastic bags for 3 weeks at 30°C. Clones in which transposon excision has led to the repair of the *ADE2* gene on pBK257 start to appear after 10--12 days. The density of clones on the plate reaches 150--200 colonies/cm^2^, i.e. 8000-11000 colonies/plates after 3 weeks. All colonies are then scraped off the plates using minimal volume of either water or SD +2% Dextrose -Adenine, pooled, and used to inoculate a 2-liter SD +2% Dextrose -Adenine culture at a density of 2.5 10^6^ cells/ml, which is allowed to grow to saturation. This step is used to dilute any remaining ade- cells, which represent about 20% of the total number of cells, and ensures that each transposition event is well represented. For example, reseeding a 2 10^6^ clones library in 2L at a density of 2.5 10^6^ cells/ml will ensure that each clone is represented by ((2.500.000 × 1000×2)\*0.8)/2.000.000 = 2000 cells. The saturated culture is harvested by centrifugation (5 min, 1600x g), washed with ddH2O, then cell pellets are frozen as \~500 mg aliquots.

Rapamycin treatment {#s4-3}
-------------------

Cells scraped off the plates were used to inoculate a 1-liter SD +2% Dextrose -Adenine culture at OD 0.08. After growing for 15 hr to OD 0.5, the culture was diluted to OD 0.1 in 500 ml SD +2% Dextrose -Adenine, treated with 10 nM (9.14 ng/ml) rapamycin (Sigma) and grown for 24 hr to OD 0.9. The culture was then diluted again to OD 0.1 in 500 ml SD +2% Dextrose -Adenine + 10 nM rapamycin. The treated culture was grown to saturation (OD 1.9), harvested by centrifugation and processed for genomic DNA extraction.

Genomic DNA {#s4-4}
-----------

A 500 mg cell pellet is resuspended with 500 μl Cell Breaking Buffer (2% Triton X-100, 1% SDS, 100 mM NaCl, 100 mM Tris-HCl pH8.0, 1 mM EDTA) and distributed in 280 μl aliquots. 200 μl Phenol:Chloroform:Isoamylalcool 25:25:1 and 300 μl 0.4--0.6 mm unwashed glass beads are added to each aliquot. Samples are vortexed for 10 min at 4°C using a Disruptor Genie from Scientific Industrial (US Patent 5,707,861). 200 μl TE are added to each lysate, which are then centrifuged for 5 min at 16100x g, 4°C. The upper layer (\~400 μl) is transferred to a fresh tube, 2.5vol 100% EtOH are added and the sample mixed by inversion. DNA is pelleted for 5 min at 16100x g, 20°C. The supernatant is removed and the pellets resuspended in 200 μl RNAse A 250 μg/ml for 15 min at 55°C, 1000 rpm on a Thermomixer comfort (Eppendorf). 2.5 vol 100% EtOH and 0.1 vol NaOAc 3 M pH5.2 are added and the samples mixed by inversion. DNA is pelleted by centrifugation for 5 min at 16100x g, 20°C. The pellets are washed with 70% EtOH under the same conditions, the supernatant removed completely, and the pellets dried for 10 min at 37°C. The pellets are resuspended in a total volume of 100 μl water for 10 min at 55°C, 700 rpm on a Thermomixer comfort (Eppendorf).

DNA is run on a 0.6% 1X TBE agarose gel against a standard 1 kb GeneRuler, and quantified using Fiji. 500 mg cell pellet should yield 20--60 μg DNA.

Library sequencing {#s4-5}
------------------

Sequencing involves the following steps: (1) Digestion of genomic DNA with two four-cutter restriction enzymes, (2) ligase-mediated circularization of the DNA, (3) PCR of the transposon-genome junctions using outward-facing primers, (4) Illumina-sequencing of the combined PCR products.

2 × 2 μg of genomic DNA are digested in parallel in Non-Stick microfuge tubes (Ambion AM12450) with 50 units of DpnII (NEB \#R0543L) and NlaIII (NEB \#R0125L), in 50 μl for 16 hr at 37°C. The reactions are then heat inactivated at 65°C for 20 min and circularized in the same tube by ligation with 25 Weiss units T4 Ligase (Thermo Scientific \#EL0011) for 6 hr at 22°C, in a volume of 400 μl. DNA is precipitated overnight or longer at −20°C in 0.3 M NaOAc pH5.2, 1 ml 100% EtOH, using 5 μg linear acrylamide (Ambion AM9520) as a carrier, then centrifuged for 20 min at 16100x g, 4°C. Pellets are washed with 1 ml 70% EtOH, for 20 min at 16100 x g, 20°C. After complete removal of the supernatant, pellets are dried for 10 min at 37°C. Each circularized DNA preparation is then resuspended in water and divided into 10 × 100 μl PCR reactions. Each 100 μl PCR reaction contains: 10 μl 10X Taq Buffer (500 mM Tris-HCl pH9.2, 22.5 mM MgCl2, 160 mM NH4SO4, 20% DMSO, 1% Triton X-100 -- stored at −20°C), 200 μM dNTPs, 1 μM primer \#1, 1 μM primer \#2, 2.4 μl homemade Taq polymerase. PCR is performed in an MJ Research Peltier Thermal Cycler PTC-200 using the following conditions:

Block: calculated -- 95°C 1 min, 35 × \[95°C 30 s, 55°C 30 s, 72°C 3 min\], 72°C 10 min.

The 2 × 10 PCR reactions are pooled into one NlaIII-digested pool and one DpnII-digested pool. 100 μl from each pool are purified using a PCR clean-up/gel extraction kit (Macherey-Nagel) according to the manufacturer protocol, with the following modifications. DNA is bound to the column for 30s at 3000x g; 30 μl of elution buffer (10 mM Tris-HCl pH8.5, 0.1% Tween) is applied to the column and incubated for 3 min, then spun for 1 min at 11000x g at 20°C. The eluate is reapplied to the column and a second elution is performed under the same conditions. Purified PCR products are quantified by absorbance at 260 nm. On a 1% agarose gel, the product runs as a smear from 250 bp to 1.2 kb, with highest density centered around 500 bp. The 867 bp size band present in the NlaIII-treated sample and the 465 bp size band present in the DpnII-treated sample correspond to untransposed pBK257. Equal amounts of DpnII- and NlaIII-digested DNA are pooled and sequenced using MiSeq v3 chemistry, according to manufacturer, adding 3.4 μl of 100 μM primer \#3 into well 12 of the sequencing cartridge.

Bioinformatics analyses {#s4-6}
-----------------------

The fastq file generated is uploaded into the CLC genomics workbench, trimmed using adaptor sequences 'CATG' and 'GATC' (the recognition sites for NlaIII and DpnII, respectively), allowing two ambiguities and a quality limit of 0.05. The trimmed sequence is then aligned to the reference genome, using the following parameters (mismatch cost, 2; insertion and deletion costs, 3; length fraction, 1; similarity fraction, 0.95; non-specific match handling, ignore). The alignment is then exported as a BAM file, which is further processed in MatLab, using the [Source code 1](#SD4-data){ref-type="supplementary-material"}, to detect individual transposition events. The outputted bed file is uploaded to the UCSC genome browser. Yeast annotations were downloaded from the Saccharomyces Genome Database (SGD). To generate our list of essential genes, we used YeastMine and searched the SGD for genes for which the null mutant has an 'inviable' phenotype ([@bib2]).

Volcano plots were computed as follows. Two sets of libraries were defined. For each gene and each library, the number of transposons per gene (tnpergene variable) was normalized to the total number of transposons mapped in the library. For each gene, the fold-change is calculated as the mean of the normalized number of transposons per gene in the experimental set, divided by that in the reference set. The *p*-value is computed using the Student's t-test by comparing, for each gene, the normalized number of transposons per gene for each library in the experimental and reference sets.

Western blotting {#s4-7}
----------------

Cells were grown to mid-log phase in synthetic minimal medium containing 0.5 g/L proline as a sole nitrogen source and stimulated with 3 mM glutamine for 2 min. Cells were treated with 6.7% w/v trichloroacetic acid (final concentration), pelleted, washed with 70% ethanol and then lyzed in urea buffer (50 mM Tris-HCl \[pH 7.5\], 5 mM EDTA, 6 M urea, 1% SDS, 0.1 mg/ml Pefabloc/phosphatase inhibitor mix). After disrupting cells with glass beads and incubating with Laemmli SDS sample buffer, samples were subjected to regular SDS-PAGE and immunoblotting. The phosphorylation level of Sch9-Thr^737^ and the total amount of Sch9 were assessed using the phosphospecific anti-Sch9-pThr^737^ and anti-Sch9 antibodies, respectively ([@bib41]).

Split-ubiquitin yeast two-hybrid assay {#s4-8}
--------------------------------------

The split-ubiquitin yeast two-hybrid system from Dualsystems Biotech AG was used following the manufacturer's instructions.

Pib2 fragments (full-length or truncated) and full-length Kog1 were cloned into pCabWT and pPR3N plasmids, respectively, and transformed into the strain NMY51 as indicated. Protein-protein interactions were detected as growth of the resultant strains on agar plates lacking adenine.

Accession numbers {#s4-9}
-----------------

Sequencing data have been deposited at EMBL-EBI ArrayExpress: E-MTAB-4885.
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10.7554/eLife.23570.023

###### Processed dataset containing (1) the position and number of reads for all transposons in each library (in the WIG format),

Processed dataset - Dpl1del.wig

Processed dataset - Mmm1Del_Vps13D716H.wig

Processed dataset - Psd2Del_Dpl1del.wig

Processed dataset - V13D716H.wig

Processed dataset - WildType1.wig

Processed dataset - WildType2.wig

Processed dataset - WT_plus_rapamycin.wig

Processed dataset - Yen1^on^.wig

summaries of the number of transposon and number of reads per gene, for all genes in each library (in the TXT format).

Processed dataset - Dpl1del_pergene.txt

Processed dataset - Mmm1Del_Vps13D716H_pergene.txt

Processed dataset - Psd2Del_Dpl1del_pergene.txt

Processed dataset - V13D716H_pergene.txt

Processed dataset - WildType1_pergene.txt

Processed dataset - WildType2_pergene.txt

Processed dataset - WT_plus_rapamycin_pergene.txt

Processed dataset - Yen1^on^\_pergene.txt

**DOI:** [http://dx.doi.org/10.7554/eLife.23570.023](10.7554/eLife.23570.023)

10.7554/eLife.23570.024

###### Table of genes appearing as essential in our analysis (i.e., their density of transposon is below 1/400 bp), but were not previously annotated as essential.

The likely explanation for the low transposon density is written in column B for each gene.

**DOI:** [http://dx.doi.org/10.7554/eLife.23570.024](10.7554/eLife.23570.024)

10.7554/eLife.23570.025

###### Data computed to draw the volcano plots ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"})

**DOI:** [http://dx.doi.org/10.7554/eLife.23570.025](10.7554/eLife.23570.025)

10.7554/eLife.23570.026

###### MatLab Script 1.

**DOI:** [http://dx.doi.org/10.7554/eLife.23570.026](10.7554/eLife.23570.026)

10.7554/eLife.23570.027

###### MatLab Script 2.

**DOI:** [http://dx.doi.org/10.7554/eLife.23570.027](10.7554/eLife.23570.027)
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The following dataset was generated:

AH Michel,R Hatakeyama,P Kimmig,M Arter,M Peter,J Matos,CD Virgilio,B Kornmann,2016,Rapid High-Resolution Functional Mapping of Yeast Genomes by Saturated Transposition,<http://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-4885/>,Publicly available at the EMBL-EBI ArrayExpress Website (accession no: E-MTAB-4885)

10.7554/eLife.23570.030

Decision letter

Deshaies

Raymond J

Reviewing editor

California Institute of Technology

,

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Functional Mapping of Yeast Genomes by Saturated Transposition\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Kevin Struhl as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

As you can see from the consolidated review below, the general evaluation of your work is quite positive, and with suitable revision it would be appropriate for publication in *eLife*. However, there were a number of specific issues that were raised, that would need to be attended to beforehand.

The most critical issues that would require new experiments are elaborated below in points \#1-2. Additional issues that would not require new experiments to address are in points \#3-5. Following that are the three original reviews. The points raised in them do not need to be addressed in a point-by-point rebuttal but they are included to give you a broader sense of the full range of issues that were raised by the three reviewers, as this may be helpful to you in the event that you make further improvements or refinements to the SATAY method.

1\) For a paper to be published in a high profile place like *eLife* (including, in cases such as this one, papers that are focused on methodology), there should be some novel biological insight reported. The insights described in the paper were, for the most part, confirming previously known connections. Given the ease of generating this data, the authors should report on a screen that revealed some new biology of significance. Because this is primarily a methodological paper, the analysis does not need to be particularly deep, but it should be sufficient to make plain that something new and interesting has been uncovered.

2\) In the synthetic-lethal screens, the \"hits\" are barely separated from the background. This can most clearly be seen in [Figure 4A](#fig4){ref-type="fig"} for the hits below the diagonal. To show the interesting hits that are discussed in the text, the authors drew an expanded box. It is apparent from looking at this box that the \'hits\' are not far from the bulk signal. This raises the question of how much intrinsic noise there is in these screens. For example, if one were to do a WT vs. WT screen (i.e. a biological replicate), would the \'spread\' of the signal in the 2D plot be as great as shown in [Figure 4A,D, and F](#fig4){ref-type="fig"}? If one knows what one is looking for it is easy to pick the needles out of the haystack. But if one is doing a novel screen and doesn\'t know what to expect, how much faith should be placed in hits that are at the edge of the data cloud, as is the case for those in [Figure 4A](#fig4){ref-type="fig"}? Performing a WT vs. WT control would shed light on this question.

3\) The authors describe in many places how this approach is superior to other genetic approaches, especially arrayed based ones. However, no specific head-to-head comparison is performed to justify this claim. For example, how would the SATAY DPL1 screen compare to other array-based procedures? In the absence of specific comparisons, the authors need to significantly attenuate their claims throughout the manuscript regarding the superiority of their method.

4\) The authors discuss the fact that several genes annotated as non-essential were found in their method to be depleted for transposition suggesting that they are essential (at least under the growth conditions used in the study). It would be useful for the authors to provide a table of all newly identified essential genes, if there are any, that previous methods may have missed due to accumulation of suppressor mutations or aneuploidy.

5\) Although the authors provide a link for a searchable platform to retrieve data, It would be beneficial to the readers if simple and clear excel tables would be provided (e.g. as supplementary tables) stating only the \"hits\" or all genes enriched/depleted for transposons in the various genetic backgrounds that the authors have tested

Reviewer \#1:

The authors describe a method for identifying transposon insertions that yield a scorable phenotype. The general approach is to induce transposition in a large population of cells that contain an inducible transposon, and then enrich for cells that exhibit a particular phenotype that is not exhibited by the initial population of wild type cells. The sites of transposon insertion in the enriched cells are then identified by high-throughput sequencing. Similar methods of transposon mutagenesis have been described in the past (e.g. Snyder). What is new here is (i) introducing deep sequencing into the workflow as a means to identify insertion sites, and (ii) the observation that insertions can be identified in intergenic regions and essential genes. In the case of essential genes, the insertions identify regions of the gene that are not essential for life but that yield a scorable phenotype when disrupted. Another point raised by the authors is that their method does not require robotics for dealing with arrayed libraries of knockout mutants. The method clearly has potential utility. The question is whether it represents a sufficient advance to merit publication in *eLife*. In my opinion, it would be important to address the two issues below prior to publication:

1\) In the synthetic-lethal screens, the \"hits\" are barely separated from the background. This can most clearly be seen in [Figure 4A](#fig4){ref-type="fig"} for the hits below the diagonal. To show the interesting hits that are discussed in the text, the authors drew an expanded box. It is apparent from looking at this box that the \'hits\' are not far from the bulk signal. This raises the question of how much intrinsic noise there is in these screens. For example, if one were to do a WT vs. WT screen (ie a biological replicate), would the \'spread\' of the signal in the 2D plot be as great as shown in [Figure 4A,D, and F](#fig4){ref-type="fig"}? This seems like an important question to resolve, because of course if one knows what one is looking for it is easy to pick the needles out of the haystack. But if one is doing a novel screen and doesn\'t know what to expect how much faith could be placed in hits that are at the edge of the data cloud, as is the case for those in [Figure 4A](#fig4){ref-type="fig"}? What would be useful here is (i) to see the WT vs. WT control, and (ii) to develop an algorithm that identifies hits in an automated manner and assigns a statistical significance to them.

2\) It would appear that this method leads to identification of transposon hops in essential genes with relatively high frequency. The 3\' insertions are easy to understand, the 5\' insertions less so. The authors suggest that perhaps these arise from spurious transcription initiation events but this is speculative and not investigated. It might be useful for future users of this method if the authors were to dig into a few of these 5\' insertions, to identify the mechanism(s) giving rise to these hits. This is especially true in this case because the primary value of the paper is as a methods paper. In that case it would be useful to have as deep an understanding of the method as possible.

Reviewer \#2:

Michel and colleagues describe in this paper an elegant new way in budding yeast to carry out genetic screens using an approach called SATAY (Saturated Transposon Analysis in Yeast), which exploits systematic transposon mutagenesis coupled to high-throughput sequencing. This interesting protocol, which seemingly can be applied to other yeast species with ease, allows for genetic interaction mapping, drug target discovery, essential gene identification and protein domain analysis.

Interestingly, they show that inter-nucleosomal regions are preferred for transposon introduction as were pericentric regions (although they demonstrated that this was due to the constructs used for the screens). They also accurately identified the essential genes in the genome (under the conditions used); and could also identify key domains in a number of proteins, including Gal10, Taf3 and Prp45. They used the approach to carry out a screen using a specific point mutant that they had previously worked on and obtained expected results based on previous work and also carried out a screen using a DPL1 mutant and reported interactions that made sense with previous work. Finally, they used SATAY in the presence of Rapamycin to identify the isomerase Fpr1, as well as other genes involved in the TOR pathway. Overall, I am very positive and excited about this paper.

However, there are two main points that I feel would need to be addressed for me to support publication in *eLife*.

1\) The authors describe in many places how this approach is superior to other genetic approaches, especially arrayed based ones. I would like to see how the interactions from this screening procedure compare to others using the same mutants. They carried out a screen with DPL1-how does the data derived from SATAY compare to other arrayed based procedures? I would like to see a few other screens and how the data compare. It may be worthwhile to have some gold standards and show via a ROC curve how this approach compares to other ones.

2\) For a paper to be published in a high profile place like *eLife* (even a methodology paper), I feel there should be some novel biological insight reported. The insights described in the paper were, for the most part, confirming previously known connections. Given the ease of generating this data, I feel there should be a few more screens (with deletions, point mutants and/or drugs), with some novel biology derived from the data.

Reviewer \#3:

The manuscript by Michel, Kimmig & Kornmann describes an innovative technology to rapidly and efficiently screen yeast for causal genomic loci. The approach, based on transposon mutagenesis followed by deep sequencing, takes advantage of the recent ease of using deep sequencing to circumvent most of the disadvantages of previous yeast screening technologies. Specifically, the new approach, termed SATAY, negates the use of arrayed libraries thus reducing the time and cost of previous screening strategies. I believe that this elegant method will be highly utilized by the yeast community. Since yeast is still the most powerful model organism for genetic screens, this technology is important and merits publication. Another potential application of this technology is its ability to map the 3D architecture of the genome with ease under a variety of conditions. In addition, the manuscript gives beautiful new insight to the domain architecture of essential genes.

10.7554/eLife.23570.031

Author response

*The most critical issues that would require new experiments are elaborated below in points \#1-2. Additional issues that would not require new experiments to address are in points \#3-5. Following that are the three original reviews. The points raised in them do not need to be addressed in a point-by-point rebuttal but they are included to give you a broader sense of the full range of issues that were raised by the three reviewers, as this may be helpful to you in the event that you make further improvements or refinements to the SATAY method.*

*1) For a paper to be published in a high profile place like eLife (including, in cases such as this one, papers that are focused on methodology), there should be some novel biological insight reported. The insights described in the paper were, for the most part, confirming previously known connections. Given the ease of generating this data, the authors should report on a screen that revealed some new biology of significance. Because this is primarily a methodological paper, the analysis does not need to be particularly deep, but it should be sufficient to make plain that something new and interesting has been uncovered.*

Our dataset uncovers over 300 domains among essential proteins. This is a unique dataset for a eukaryotic genome. We understand, however, that to demonstrate that our method is also useful for comparative library screening, we must show more than proof-of-principle and confirmation of previously known connections.

We have therefore included true biological findings from 2 screens that were part of the original manuscript and from an additional library.

1\) One strength of our approach is to identify situations where genes insofar deemed essential become dispensable. We have identified two such cases in our screens and confirmed the interactions by classical tetrad analysis.

The first concerns the septin Cdc10. CDC10 is essential for growth at 30˚C but not at 25˚C. We find that cdc10 deletion lethal phenotype at 30˚C is partially alleviated by the deletion of DPL1. Dpl1 being is a negative regulator of sphingolipid accumulation, this result suggests that altering membrane composition renders Cdc10 dispensable, thus hinting at an important role of membrane lipids in septin ring assembly. These finding constitutes the new [Figure 5](#fig5){ref-type="fig"}, panels A-C.

The second concerns the essential replication factor Dna2. We generated a SATAY library in a strain expressing a constitutively active version of the Holliday-junction resolvase Yen1. We observe that DNA2 becomes dispensable in this strain, indicating that Yen1 could substitute entirely for Dna2 function, provided that it is constitutively active. This finding challenges previous functions attributed to both Yen1 and Dna2 and constitutes the new [Figure 5](#fig5){ref-type="fig"}, panels D-F.

2\) Another unique strength of our approach is to unveil domain organization in proteins. We had identified Pib2 N-terminal truncations as causing a possible gain-of-function rapamycin resistance. We have investigated the phenomenon further. We find that Pib2 is an activator of the Target-of-rapamycin complex 1 (TORC1) and, guided by the transposon map, confirm that N-terminus pib2 truncations lead to semi-dominant rapamycin resistance. We originally assumed that the N-terminus negatively regulated Pib2 activity, possibly via an allosteric mechanism. Instead, further analyses showed that Pib2 possesses two independent antagonistic activities; one that stimulates and one that represses TORC1. N-terminal truncations of Pib2 activate TORC1 in a semi-dominant manner, while C-terminal truncations repress TORC1, also in a semi-dominant manner. Thus, our data unveil an entirely unanticipated architecture in Pib2, bearing two antagonistic activities. As the mechanisms for nutrient sensing by TORC1 are unclear, our data suggest that an upstream player can act both as an activator and a repressor of TORC1 depending on the conditions. It is, to the best of our knowledge, unheard of that a protein bears two antagonistic activities at each end of the polypeptide chain. These finding are described in the [Figure 6](#fig6){ref-type="fig"}, new panels C-H, and the new [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}.

*2) In the synthetic-lethal screens, the \"hits\" are barely separated from the background. This can most clearly be seen in [Figure 4A](#fig4){ref-type="fig"} for the hits below the diagonal. To show the interesting hits that are discussed in the text, the authors drew an expanded box. It is apparent from looking at this box that the \'hits\' are not far from the bulk signal. This raises the question of how much intrinsic noise there is in these screens. For example, if one were to do a WT vs. WT screen (i.e. a biological replicate), would the \'spread\' of the signal in the 2D plot be as great as shown in [Figure 4A,D, and F](#fig4){ref-type="fig"}? If one knows what one is looking for it is easy to pick the needles out of the haystack. But if one is doing a novel screen and doesn\'t know what to expect, how much faith should be placed in hits that are at the edge of the data cloud, as is the case for those in [Figure 4A](#fig4){ref-type="fig"}? Performing a WT vs. WT control would shed light on this question.*

Our original submission contained two wild-type libraries, and their pairwise comparison indeed showed a significant spread (not shown). As pointed by reviewer \#1, the fact that noise may blur the signal from the datasets is indeed an important issue that was not addressed in our previous manuscript.

The issue is particularly important when comparing libraries in a pairwise fashion, as we do in [Figure 4](#fig4){ref-type="fig"}. This issue however withers when a library is not compared in a pairwise fashion to another library, but is compared to a pool of other libraries. For instance, a hit can be confidently identified by manually verifying it in the genome browser and comparing transposon accumulations across all libraries. This is exemplified in [Figure 4B,C,E and G](#fig4){ref-type="fig"}. We understand of course that this manual step is not satisfactory. We have resolved the issue by computing a metrics that allows to compare a library against a set of libraries, or sets of libraries against each other, and devised a way to graphically display the comparisons ([Figure 4 ---figure supplement 1](#fig4s1){ref-type="fig"}). We calculated the average transposon number per gene in each library set and determined a fold change across sets. We associated the fold change with a confidence score (based on a Student's t-test), that reflects the spread in transposon number within each set. We generated volcano plots in which genes are plotted according to the fold change (x-axis) and the confidence score (y-axis). Using this approach, the hits are well separated and noise is efficiently cancelled out.

Moreover, this approach is very versatile. One library can be compared against all other libraries available, or a chosen set of libraries against another chosen set, depending on the question asked.

*3) The authors describe in many places how this approach is superior to other genetic approaches, especially arrayed based ones. However, no specific head-to-head comparison is performed to justify this claim. For example, how would the SATAY DPL1 screen compare to other array-based procedures? In the absence of specific comparisons, the authors need to significantly attenuate their claims throughout the manuscript regarding the superiority of their method.*

We understand this concern and have soften and clarified our wording; we do not know and do not claim that our approach is superior to library-based screens in terms of quantativity, sensitivity, robustness or reproducibility. That said, our approach bears a set of specific advantages over library- based screens as it allows the discovery of protein domains, the screening of the coding and non- coding genomes, and the discovery of a diversity of alleles. It is amenable to complex genetic backgrounds, and requires only simple equipment. Our approach is advantageous over classical mutagenesis in that it is much more comprehensive.

We have removed several sentences where we made possibly misleading statements comparing our approach to library-based screens. We have added full paragraphs in the Results and the Discussion sections to indicate the potential pitfalls in terms of signal-to-noise ratio (see above), and ways to circumvent them.

While it is, in principle, a great idea to compare our *DPL1* library with published library-based screens, *DPL1* unfortunately does not genetically interact with many high-confidence hits, neither in our data, nor in published datasets. Its best negative-genetic interactor, according to Boone et al. (thecellmap.org) is *LCB3* (score -0.851). This gene makes a lot of sense, since it is, like *DPL1*, involved in the turnover of dihydro- and phytosphingosin-phosphate. We also found it among our best hits. The second best hit of Boone et al. is *RAD1* with a score (-0.479) that is already half of LCB3's. *RAD1* is a DNA repair protein, and a genetic interaction with LCB3 is difficult to make sense of. It is quite likely a false positive. RAD1 does not show a particular genetic interaction in our libraries. So specific head-to-head comparison is difficult.

*4) The authors discuss the fact that several genes annotated as non-essential were found in their method to be depleted for transposition suggesting that they are essential (at least under the growth conditions used in the study). It would be useful for the authors to provide a table of all newly identified essential genes, if there are any, that previous methods may have missed due to accumulation of suppressor mutations or aneuploidy.*

We filtered our dataset to find genes with lowest transposon density and included them in such a list ([Supplementary file 2](#SD2-data){ref-type="supplementary-material"}). Genes present in this list can be classified as follow:

1\) Genes that are repeated. Our mapping strategy does not map reads that can be ambiguously mapped to more than one place in the genome. Therefore repeated genes appear as transposon-free,

2\) Auxotrophy genes. We grow cell on synthetic medium, therefore many genes that confer prototrophy to a chemical that is absent from our medium appear as tansposon-free.

3\) Galactose pathway genes. Since we grow cells on galactose, they require an intact galactose pathway.

4\) Clearly misannotated genes. Some genes are known to be essential, yet they do not bear the "null mutant: inviable" GO-term that we used to populate the list of essential genes.

5\) ORFs that overlap with essential genes. Several annotated dubious ORFs actually overlap with essential genes on most of their length.

6\) New essential genes. The genes that do not fall into any of the above category represent potential new essential genes.

However we would like to raise attention to the intrinsic problems of classifying genes as either "essential" or "non-essential". This problem is not specific to our approach, and we suspect that many genes lie in a grey zone between "essential" and "non-essential", depending on the method used to address their "essentiality". In our case, a mutation that slows down yeast growth by a factor of, say, 100 will cause a transposon-free area on our maps, yet the gene might not be considered as essential sensu stricto. We suspect that many genes that have a low transposon density are not essential sensu stricto, but their mutation renders cells extremely sick.

Yet, we note that, as anticipated by reviewer \#3, 12 duplicated ribosomal protein genes appear in the list of new essential genes (e.g. RPL11A). Such genes are likely to be compensated for in deletion libraries, for instance by duplicating the chromosome bearing the second copy of the gene (e.g. RPL11B). The fitness as assessed by our method is indeed likely to reflect the fitness of an unadapted mutant strain.

*5) Although the authors provide a link for a searchable platform to retrieve data, It would be beneficial to the readers if simple and clear excel tables would be provided (e.g. as supplementary tables) stating only the \"hits\" or all genes enriched/depleted for transposons in the various genetic backgrounds that the authors have tested.*

We have added the requested full excel tables with scores used to compute the volcano plots ([Supplementary file 3](#SD3-data){ref-type="supplementary-material"}, see above), as well as the transposon per genes and reads per genes for each library (Processed Dataset).

[^1]: \* The harvested library was grown in two flasks, one at 30°C and the other at 37°C. DNA was extracted separately from the two cultures and sequenced in two separate MiSeq runs.

[^2]: † The library was harvested as ten subpools, which were grown in ten separate flasks. DNA was extracted separately. In one case, DNA from all ten subpools was pooled and processed to sequencing in one MiSeq run. In the other case, DNAs were kept separate and processed until the PCR step (1 × 100 µl PCR by subpool). PCR products were pooled and sequenced as another MiSeq run.

[^3]: ^\*^*ADE2* deleted −56 before ATG +62 after STOP with PCR primers \#6 and \#7 on pFA6a-His3MX6.

[^4]: Oligonucleotides \#1 and \#2, ordered as PAGE-purified and lyophilized, are resuspended at 100 μM in water. Oligonucleotide \#3, ordered as HPLC-purified and lyophilized, is resuspended at 100 μM in water and distributed into single-use aliquots.
